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                                                                         Abstract 
Researcher: Daniel Mark Bull 
Title: The Effects of Energy Beverages in Counteracting the Symptoms of Mild 
Hypoxia at Legal General Aviation Altitudes 
 
Institution: Embry-Riddle Aeronautical University 
Degree: Master of Science in Aeronautics 
Year: 2012 
The purpose of this thesis was to conduct preliminary research, in the form of a pilot 
study, concerning the natural effects of hypoxia compared to the effects of hypoxia 
experienced after the consumption of an energy beverage. The study evaluated the effects 
of hypoxia on FAA certificated pilots at a simulated legal general aviation altitude, 
utilizing the normobaric High Altitude Lab (HAL) located at Embry Riddle Aeronautical 
University, Daytona Beach, Florida. The researcher tested 11 subjects, who completed 
three simulated flight tasks within the HAL using the Frasca International Mentor 
Advanced Aviation Training Device (AATD). The flight tasks were completed after 
consuming Red Bull
®
, Monster
®
, or a placebo beverage. The researcher derived three test 
variables from core outputs of the AATD: lateral deviations from the glide slope, vertical 
deviations from the localizer, and airspeed deviations from the target speed of 100 knots. 
A repeated-measures ANOVA was carried out to determine effects of the beverages on 
the test variables. While results were non-significant, the researcher concluded that 
further research should be conducted with a larger sample.
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Chapter I 
Introduction 
Since the beginning of time, humans have been fascinated with the miracle of 
flight. As humankind has developed and technology has advanced, there has been 
continued pressure to go faster, make aircraft stronger, and fly aircraft higher. 
Humankind is obsessed with pushing machinery to its limits in the name of science, 
education and discovery. In the voyage of discovery, humankind has celebrated 
achievements in obtaining the best results possible from, not only ourselves, but also our 
creations (Dempsey & Gesell, 2010). 
In this study, the researcher recognized that, as technologically advanced aircraft 
are accessible to a greater number of General Aviation (GA) pilots, it is increasingly 
possible to operate aircraft that are able to achieve altitudes greater than ever before. The 
Federal Aviation Administration (FAA) states that there is a positive correlation between 
altitude and fuel consumption (Federal Aviation Administration [FAA], 2012). Therefore, 
pilots would naturally climb to the highest altitude possible to experience the best 
possible performance from their aircraft. The legal limit to which a GA pilot may climb 
without supplementary oxygen is 14,000 feet above mean sea level (MSL) (Certification: 
Pilots, Flight Instructors, and Ground Instructors Rule, 2010).   
FAA (2011) also notes that at altitudes as low as 5,000 feet MSL, a pilot may 
experience symptoms of hypoxia. Altitude-hypoxia is a condition that occurs in the body 
due to the reduction of air pressure as altitude increases. As a result, there is a reduction 
in the body’s efficiency to absorb oxygen (FAA, 2011). Darwish (2003) states that the 
symptoms of hypoxia can be classified into five stages, which relate to the saturation of 
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oxygen found in the body in correlation with increasing altitude. Symptoms can range 
from reduced night-vision in low-altitude hypoxia, to a worst-case scenario of 
cardiovascular collapse in high-altitude hypoxia (Darwish, 2003). However, each 
individual has his or her own tolerances to hypoxia, which can result in different levels of 
severity of symptoms (Darwish, 2003). 
Low-altitude hypoxia, as defined by Darwish (2003), is also noted by FAA (2011) 
to occur between “12,000 to 15,000 feet MSL of altitude” in which “judgment, memory 
alertness, coordination and ability to make calculations are impaired, and headache, 
drowsiness, dizziness and either a sense of well being (euphoria) or belligerence occur” 
(p. 922). The researcher conducted an interview regarding low-altitude hypoxia with Dr. 
C. Howell, an expert in Aviation Human Factors, Human Physiology, Aviation Safety, 
Crew Resource Management, Situational Awareness, and NextGen General Aircraft 
(Embry-Riddle Aeronautical University [ERAU], 2012).  Dr. C. Howell suggested that 
energy beverages could potentially reduce the symptoms experienced in a low-altitude, 
hypoxic environment. He based this statement on his personal observations noted when 
flying his own aircraft at the upper legal limits (Dr. C. Howell, personal communication, 
November 15, 2010).  Energy beverages have a range of active ingredients, which have 
been reputed to improve mental focus, increase oxygen intake, and improve alertness 
(Smit & Rogers, 2002). The researcher was interested in discovering whether energy 
beverages could have an effect on a pilot when in a low-oxygen environment. 
Through the compulsory education required in achieving any level of pilot 
qualification, pilots should be aware of all elements of hypoxia. However, many pilots 
may be unaware of the severity of the dangers found in the symptoms of hypoxia. The 
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guidelines surrounding altitudes where hypoxia may occur are diverse and often 
inconsistent, even among the publications produced by the regulatory control bodies.  
The researcher was interested in whether consuming an energy beverage before flight 
could result in a reduction of the symptoms of hypoxia at altitudes where there is 
potential for hypoxia. 
Significance of the Study 
This study holds great importance, as currently the only mention of beverages as 
prescribed for GA pilots by the US government concerning alcohol consumption (FAA, 
2011). This study covered areas of research where the outcome could be significant for 
pilots, the FAA, and Aero-Medical boards. Therefore, the study could produce a safety 
recommendation for pilots to take precautions against the symptoms of hypoxia through 
the consumption of an energy beverage. 
The rules published by the FAA suggest that GA pilots may fly as high as 12,500 
feet MSL any time, and up to 14,000 feet MSL for 30 minutes, without a requirement for 
supplementary oxygen (Supplemental Oxygen Rule, 2010). However, the FAA also 
states that the effects of hypoxia can be present at an altitude of 5,000 feet MSL at night 
(FAA, 2011). Therefore, it is important that pilots can recognize hypoxia, the potential 
dangers, and possible ways of counteracting its symptoms. Research suggests that 
hypoxia can affect individuals differently, depending on their individual tolerances and 
general condition of health (Darwish, 2003). The variable factors are smoking, weight, 
alcohol consumption, fitness, and prescribed medication (FAR, 2011).  
It was noted by an experienced pilot that there was an observed decrease in the 
recognized effects of hypoxia from flying at altitudes between 10,000 and 14,000 feet 
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MSL when consuming an energy beverage before flight. Upon further exploration it was 
discovered that the positive effects of energy beverages have been evaluated in scenarios 
related to driving (Mets et al., 2010), concentration (Smit & Rogers, 2002), and in 
research on armed forces personnel, but not in relation to flying  (Tharion, Montain, 
O'Brien, Shippee, & Hoban, 1997). Since there has been no research regarding energy 
beverages and low-altitude hypoxia, the researcher believed there was an opportunity for 
research which would be of interest to the aviation community. 
Statement of the Problem 
The FAA prescribes regulations about the acceptable altitudes where a GA pilot 
may fly unaided by supplementary oxygen or pressurization. It is apparent that there are 
differences between these regulations and other regulations. For example, the 
Supplemental Oxygen Rule (2010), which is the guideline for most GA pilots, states that 
pilots may fly up to but not including 12,500 feet MSL, without supplementary oxygen. 
The Supplemental Oxygen Rule (2010) also states that a pilot may fly between 12,500 
feet MSL and 14,000 feet MSL for 30 minutes without supplemental oxygen before 
returning to below 12,500 feet MSL, and a pilot must use supplemental oxygen to fly 
above 14,000 feet MSL. However, the Aircraft Certification and Equipment 
Requirements Rule (2010), for Part 121 carriers, states that crewmembers must be on 
supplemental oxygen at all times above 12,000 feet MSL. This is regardless of the period 
of time they are above the altitude and notably stricter than the rules prescribed by the 
Supplemental Oxygen Rule (2010). The Pilot Requirements: Use of Oxygen Rule (2010) 
for Part 135 carriers states that, in the case of unpressurized aircraft, a pilot must use 
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oxygen above 10,000 feet MSL through 12,000 feet MSL if longer than 30 minutes in 
duration, and at all times above 12,000 feet MSL. 
In addition to the differences in the prescribed rules regarding altitude, it is also 
suggested that all pilots would be equally affected by low-altitude hypoxia. However, it is 
documented by FAA (2011) that pilots have varying tolerances to hypoxia. The 
researcher believed there could be issues arising from inconsistencies in the prescribed 
rules regarding altitude, and a possibility that some pilots may experience varying 
severity of symptoms.  It was therefore important to analyze whether and to what extent 
an energy beverage could potentially help pilots to cope with the symptoms of hypoxia 
when operating at the upper legal limits of the prescribed rules. 
Purpose Statement 
The purpose of this study was to determine the effects of an energy beverage on 
symptoms of hypoxia by simulating the legal flight altitude of 14,000 feet MSL and 
exposing subjects to the symptoms of low-altitude hypoxia. The researcher provided the 
subjects with energy beverages and a placebo to evaluate whether there were any effects 
on possible symptoms of mild hypoxia. 
Hypothesis  
The following hypothesis was tested: There will be a difference in the effects of 
hypoxia between pilots who consumed an energy beverage before completing a simulated 
instrument approach at a simulated altitude of 14,000 feet MSL and pilots who did not, 
among college students at Embry-Riddle Aeronautical University, Daytona Beach, 
Florida Campus. 
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Delimitations 
The subjects were self-elected students of Embry-Riddle Aeronautical University, 
Daytona Beach, Florida campus. The students were between 18-30 years of age and had 
maintained a pilot’s license with an instrument rating and at least a second-class medical 
certificate at the time of testing. 
The researcher exposed the subjects to the simulated upper legal limit of 14,000 
feet MSL to enhance the possibility that the symptoms of low-altitude hypoxia would be 
present. The subjects remained at the simulated 14,000 feet MSL altitude for the entire 
testing phase. The testing phase did not exceed the legal limit of 30 minutes. The 
researcher evaluated whether the energy beverage had an effect on the subjects’ 
performance in respect to lateral deviations, vertical deviations, and airspeed deviations 
while performing a simulated instrument approach.  
The subjects were limited to performing the simulated flight tasks utilizing the 
Frasca™ Mentor Advanced Aviation Training Device (AATD) (Frasca International, 
2011). The AATD was used to test the subjects’ performance while flying an instrument 
approach in a typical GA aircraft.  
The testing was limited to the normobaric High Altitude Lab (HAL). The HAL 
was capable of simulating an environment which is consistent with being at 14,000 feet 
MSL (Colorado Altitude Training [CAT], 2009). 
Limitations and Assumptions 
The subjects were required to complete three separate test sessions, in which they 
consumed a different beverage each time. The subjects did not know which beverage they 
were consuming at each test session; however, they were aware of the range of 
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ingredients in all beverages. Subjects were blind to the beverage type to eliminate any 
psychological effect on subjects’ performances. 
The subjects were also not aware of the altitude that the HAL was simulating. As 
previously stated, the experiment never exceeded the altitudes defined by FAA 
regulations in the Supplemental Oxygen Rule (2010). The altitude showed a constant 
14,000 feet MSL; however, the HAL has a 1-3% level of error, and as such cannot keep 
to 14,000 feet MSL constantly (CAT, 2009). 
The method of recruiting the subjects did not allow the researcher to select 
subjects with similar attributes such as skill and qualification level, height, weight, 
gender etc.; therefore, the researcher did not expect to observe a pattern of similar results. 
The subjects were given a pre-test survey, and the accuracy of this survey was dependent 
on the subjects’ willingness to be honest. It was assumed that the subjects were forthright 
in completing the pre-test survey. 
 It was assumed that the lab technicians were accurate in following the methods 
and procedures of research and conducted the experiment the same way for every subject. 
It was assumed that the accuracy of the instruments was consistent for all of the tests. 
Definitions of Terms 
14 CFR § 91 - Section of the CFRs that covers general operations of aircraft in the 
Airspace System (General Operating and Flight Rules, 2010) 
14 CFR § 121 - Section of the CFRs that covers scheduled air carrier’s operations in the 
Airspace System (Operating Requirements: Domestic, Flag, and Supplemental 
Operations Rules, 2010). 
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14 CFR § 135 - Section of the CFRs that covers non-scheduled air carrier’s operations in 
the Airspace System (Operating Requirements: Commuter and On Demand 
Operations and Rules Governing Persons On Board Such Aircraft Rules, 2010) 
Blood Oxygen Content - A measure of how many O2 molecules are in the blood. 
Measured as a percentage of a 100% total (FAA, 2011) 
Dot – Unit of measurement used to represent a deviation from the glide slope, equal to 
200 feet MSL (FAA, 2011) 
Hypobaric - A decrease in atmospheric pressure in relation to normal ambient pressure 
(FAA, 2011) 
Hypoxia - A state of having less oxygen than required for normal bodily and cognitive 
function. (FAA, 2011) 
Hypoxic Hypoxia - The effect that is caused by a lack of atmospheric pressure. This lack 
of oxygen in the body is due to the inability of the oxygen to cross through the 
membrane of the lungs into the blood stream. (FAA, 2011) 
Normobaric - Standard Sea Level Pressure in relation to the lab (FAA, 2011) 
List of Acronyms 
AATD               Advanced Aviation Training Device   
AC                    Advisory Circular 
ADM                Aeronautical Decision Making 
AGL                 Above Ground Level 
AIM                 Aeronautical Information Manual 
ASMA              Aerospace Medical Association 
BPM                 Beats Per Minute 
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CAT                 Colorado Altitude Training 
CFR                  Code of Federal Regulations 
DCS                  Decompression Sickness 
DoD                  Department of Defense 
DoT                  Department of Transportation 
EEG                  Electroencephalogram 
ERAU               Embry-Riddle Aeronautical University 
FAA                  Federal Aviation Administration 
FAR                  Federal Aviation Regulations 
GA                    General Aviation 
GS                    Glide Slope 
HAL                 High Altitude Lab 
IAS                   Indicated Air Speed 
ILS                   Instrument Landing System 
IRB                  Institutional Review Board 
MSL                 Mean Sea Level 
NTSB               National Transportation Safety Board 
SL                    Sea Level 
SpO2                Saturation of Oxyhemoglobin          
TUC                 Time of Useful Consciousness 
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Chapter II 
Review of the Relevant Literature 
The researcher consulted the regulatory sources to ensure that this research would 
be in accordance with regulated pilot rules. The legislation was used to identify rulings 
for pilots subjected to an unpressurized environment and without supplemental oxygen, 
where hypoxic symptoms may occur. The rules regarding the level of exposure a pilot 
may have to a reduced oxygen environment were consulted to ensure that the experiment 
would be designed and conducted correctly, thus protecting the subjects from harm and 
producing results that would be relevant to potential real life scenarios (Supplemental 
Oxygen Rule, 2010). 
FAA Regulations 
The FAA is the governing body for all aspects of civil aviation in the United States. 
The primary responsibility of the FAA is to regulate the Civil Aerospace system in the 
US for both domestic and international pilots and aircraft (FAA, 2011). The FAA also 
regulates the air traffic control facilities, controls certification for pilots and aircraft, and 
promotes safety. The promotion of safety is achieved by reducing risk through 
regulations.  
The Code of Federal Regulations (CFR) is the framework and codification for the 
rules that are published through the Federal Register on behalf of the Executive 
Departments of the Federal Government (“Code of Federal Regulations” [CFR], 2010). 
The CFRs are sectioned into 50 titles and represent all major departments and agencies 
within the FAA. The titles are then divided further into chapters, which are then 
subdivided into parts (CFR, 2010). 
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For the purpose of this study, the applicable Title 14: Aeronautics and Space was of 
interest, in particular, Part 91, the General Operating and Flight Rules (2010). Under 
Subpart C, Equipment, Instrument and Certificate Requirements, the rules on operating a 
U.S. registered aircraft are specified. The rules found under Part 91, Subpart C, govern 
most GA pilots and state that no person may operate outside of these conditions. The 
code states: 
No person may operate a civil aircraft of U.S. registry—  
(1) At cabin pressure altitudes above 12,500 feet MSL up to and including 14,000 
feet MSL unless the required minimum flight crew is provided with and uses 
supplemental oxygen for that part of the flight at those altitudes that is of more 
than 30 minutes duration. 
(2) At cabin pressure altitudes above 14,000 feet MSL unless the required 
minimum flight crew is provided with and uses supplemental oxygen during the 
entire flight time at those altitudes. 
(3) At cabin pressure altitudes above 15,000 feet MSL unless each occupant of the 
aircraft is provided with supplemental oxygen. (Supplemental Oxygen Rule, 
2010).  
The ruling for GA is, in fact, more relaxed compared to Part 121, regarding 
Supplemental Oxygen: Reciprocating Engine Powered Airplanes Rule (2010) that 
governs scheduled air carriers. The effects of hypoxia do not tend to be a problem for 
passengers and crew because the aircraft are pressurized; whereas, most GA aircraft do 
not operate with a pressurized cabin. For Part 121 operators the guidelines state:  
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(1) At cabin pressure altitudes above 10,000 feet MSL up to and including 12,000 
feet MSL, oxygen must be provided for, and used by, each member of the flight 
crew on flight deck duty, and must be provided for other crewmembers, for that 
part of the flight at those altitudes that is of more than 30 minutes duration. 
(2) At cabin pressure altitudes above 12,000 feet MSL, oxygen must be provided 
for, and used by, each member of the flight crew on flight deck duty, and must be 
provided for other crewmembers, during the entire flight time at those altitudes. 
(Supplemental Oxygen: Reciprocating Engine Powered Airplanes Rule, 2010, p. 
327). 
The Supplemental Oxygen: Reciprocating Engine Powered Airplanes Rule (2010) 
suggests it may be possible to experience symptoms of hypoxia as low as 10,000 feet 
MSL. The same rules are outlined in the Pilots Requirements Rule: Use of Oxygen 
(2010) which concerns all those who operate under Part 135. The Pilots Requirements 
Rule (2010) states that all pilots of unpressurized aircraft must carry supplemental 
oxygen for use when operating above 12,000 feet MSL, or between 10,000 feet MSL to 
12,000 feet MSL if longer than 30 minutes. In Part 121 and Part 135, the passengers and 
crew are the number one priority for safety, hence the stricter rules. Therefore, the FAA 
may feel it necessary to use tighter tolerances despite no immediate danger from a 
hypoxic environment. 
Hypoxia  
The FAA Aeronautical Information Manual (AIM) is published annually by the 
Department of Transportation (DOT) as a quick reference guide (FAA, 2011). It covers 
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all necessary data required by GA pilots, sports pilots and instructors in an easy-to-find-
format. Relevant information is described below. 
 Symptoms of hypoxia.   FAA (2011) provides medical facts for pilots, including 
information on hypoxia. It defines hypoxia: 
(1) Hypoxia is a state of oxygen deficiency in the body sufficient to impair 
functions of the brain and other organs. Hypoxia from exposure to altitude is 
due only to the reduced barometric pressure encountered at altitude, for the 
concentration of oxygen in the atmosphere remains about the 21 percent from 
the ground out to space.  
(2) Although deterioration in night vision occurs at cabin pressure altitudes as low 
as 5,000 feet, other significant effects of altitude hypoxia usually do not occur 
in the normal healthy pilot below 12,000 feet. From 12,000 to 15,000 feet of 
altitude, judgment, memory, alertness, coordination and ability to make 
calculations are impaired, and headache, drowsiness, dizziness and either a 
sense of well being (euphoria) or belligerence occur. The effects appear 
following increasingly shorter periods of exposure to increasing altitude. In 
fact, pilot performance can seriously deteriorate within 15 minutes at 15,000 
feet. (FAA, 2011, p. 922). 
The FAA states that the effects of altitude hypoxia are, in fact, due to changes in 
barometric pressure and not due to the lack of oxygen in the air, as endorsed by the 
Aerospace Medical Association (ASMA) (FAA, 2011).The ASMA is highlighted as 
being a resource to help recognize the effects of hypoxia. It advises that pilots undertake 
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a physiological training program to become more knowledgeable in recognizing the 
symptoms of hypoxia (FAA, 2011).  
According to the FAR, the effects can be present as low as 5,000 feet MSL at 
night and from 12,000 feet MSL during the day, and that supplemental oxygen should be 
carried at these altitudes (FAA, 2011).  
The FAA (2011) explains that the symptoms of hypoxia can be more significant 
among smokers and if carbon monoxide is inhaled from the exhaust. Other accelerators 
of the symptoms can include the presence of small amounts of alcohol in the body, 
certain prescription drugs, cabin temperature, colds, fevers, or anxiety (FAA, 2011). The 
FAA concludes by stating that the effects of hypoxia are extremely difficult to recognize 
without proper training. In order for GA pilots to be fully protected, the FAA suggests 
supplemental oxygen be used when operating above 10,000 feet MSL during the day, and 
5,000 feet MSL at night (FAA, 2011). 
Symptoms of hypoxia are difficult to identify, and it is pertinent to highlight that 
the symptoms vary in severity depending on the stage of onset (FAA, 2011). There are 
four levels of hypoxia, and each one has a set of symptoms related to the saturation of 
oxygen in the body. Darwish (2003) defines the stages as listed in Table 1. 
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Table 1 
 
Symptoms of Hypoxia 
Stages Indifferent 
(99%-95% 
O2 
saturation) 
Complete 
Compensatory 
(94%-85% O2 
saturation) 
Partial 
Compensatory 
(84%-70% O2 
saturation) 
Critical 
(69% and 
lower O2 
saturation) 
Altitude 
(thousands 
of Feet 
MSL) 
0-5 5-11 11-18 Above 18 
Symptoms Decrease 
in night 
vision 
 
Tingle behind 
throat 
Impaired vision Circulatory 
failure 
  
Impaired 
situational 
awareness 
 
Impaired flight 
control 
Convulsions 
  
Euphoria Impaired Judgment Cardiovascular 
collapse 
 
  
Drowsiness Impaired efficiency Death 
 
  
Poor 
judgment 
Impaired 
handwriting 
 
 
  
 Impaired speech  
  
  
Decreased 
coordination 
 
  
 Decreased 
sensation to pain 
 
  
  
 
Decreased memory 
 Note. Adapted from “Aerospace Medicine: Part 1,” by A.A. Darwish, 2003, The Internet 
Journal of Pulmonary Medicine, 3 (2), p. 16. 
 
 
 
The stages highlighted by Darwish (2003) are defined as those experienced by an 
average healthy pilot. However, as denoted by FAA (2011), individuals have different 
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tolerances to hypoxia. As a result, it is assumed that an individual may experience more 
severe symptoms at a lower altitude than described in Table 1. 
A study to evaluate the effects of hypoxia on pilot performance at GA altitudes 
was conducted by the FAA (Nesthus, Rush, & Wreggit, 1997). The purpose of that study 
was to analyze whether symptoms of hypoxia were present under the prescribed 12,500 
feet MSL, given that individuals can show varying tolerances. Nesthus et al. (1997) 
defined hypoxia as “a state of oxygen deficiency in the blood, cells, or tissue of the body 
sufficient to cause an impairment of function” (p. 12).  Nesthus et al. (1997) noted: 
In aviation, a reduction in total atmospheric pressure occurs with increasing 
altitude. This change produces a reduction of oxygen partial pressure (PO2) and 
hence, a reduction of alveolar Oxygen Pressure and the pressure gradient between 
the alveoli and mixed venous blood in the pulmonary capillaries. By breathing the 
ambient air of a reduced pressure environment, less oxygen diffuses across the 
alveolar-capillary membranes into the blood stream and to the tissues of the body.                    
(p. 13)   
 
Nesthus et al. (1997) also asserts that the body requires a constant level of oxygen 
intake if it is to function correctly, and that the brain uses one-fifth of the oxygen we 
consume. This is compared to the fact that the brain only represents 2% of the body’s 
total weight (Nesthus et al., 1997). 
The brain’s ability to function correctly was analyzed further in a 
neurophysiology article relating to the topographic changes due to hypobaric hypoxia at 
simulated altitudes (Ozaki, Watanabe, & Suzuki, 1995). Ozaki et al. (1995) tested brain 
activity against its sensitivity to oxygen supply by measuring the electrical activity and 
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functional state when hypoxic. The results showed that, as altitude increased, the 
influences of hypoxia affected the physiological parameters (Ozaki et al., 1995). The 
12,000 feet MSL stage results of the experiment were most applicable to the 12,500 feet 
MSL upper legal limit (more than 30 minutes) prescribed by the FAA for GA pilots 
without the need for supplemental oxygen (FAA, 2011). The results showed the brain’s 
cognitive function significantly decreased at 12,000 feet MSL, compared to sea level 
(Ozaki et al., 1995). Ozaki et al. suggested that the first stage of hypobaric hypoxia is 
caused by suppression of alpha Electroencephalogram (EEG) activity. However, these 
effects can be skewed by the pilot’s skill level and tolerances to the effects of hypoxia 
(Ozaki et al., 1995), which are further discussed by Fiorica, Burr, and Moses (1977). 
Fiorica et al., (1977) explored how pilots can perform vigilance tasks at an equivalent 
flight level of 11,500 feet MSL. Despite the results proving to be statistically 
insignificant, pulse-oximeter readings taken from the pilots revealed a concerning 
saturation in their blood oxygen levels and deterioration in vigilance performance 
(Fiorica et al., 1977). However, the nature of the experiment was reported as being too 
simple and requiring minimal muscular activity; therefore, it was suggested that the 
patterns seen would have been far more severe if the vigilance indicators had been more 
sophisticated (Fiorica et al., 1977). 
Energy and Sports Beverages 
For the purpose of this study, it is important to note that energy and sports 
beverages are defined as two separate beverage types as classified by Kotke and Gehrke 
(2008). The purpose of an energy drink is to provide the consumer with a burst of energy 
via a cocktail of ingredients that stimulate the body to become more alert and active 
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(Kotke & Gehrke, 2008). The energy drink is also marketed for mental stimulation 
effects as denoted by Amendola, Iannilli, Restuccia, Santini, and Vinci (2004). A sports 
drink is targeted at athletes, with a purpose of rehydrating the athlete and replenishing 
energy and nutrients lost with sugars, vitamins and minerals (Kotke & Gehrke, 2008).  
Core active ingredients in energy beverages.  Most energy drinks contain 
herbal supplements, such as Guarana, Yerba Mate leaves, Pannax ginseng, ginko biloba, 
and milk thistle (Kotke & Gehrke, 2008). The most common active ingredient found in 
energy beverages is caffeine, which has various doses based on the exact type and 
marketed audience of the product (Kotke & Gehrke, 2008). Typically, the variation of 
caffeine ranges from 2.5 mg to 171 mg per fluid ounce (Reissig, Strain, & Griffiths, 
2008). Caffeine, a central nervous system stimulant, is claimed to improve alertness and 
reaction times (Kotke & Gehrke, 2008). Other studies have shown caffeine increases 
long-term athletic performance and improves speed and power output (Reissig et al., 
2008). Additionally, caffeine has been attributed to improving mental function and 
efficiency on vigilance tasks (Reissig et al., 2008).  
Taurine is the second most commonly found key active ingredient in energy 
beverages (Amendola et al., 2004; Kotke & Gehrke, 2008). Taurine lowers the heart rate 
and noradrenalin concentration, according to Gershon, Shinar, and Ronen (2009), and is 
used in the beverages to balance the caffeine intake. Deixelberger-Fritz, Tischler and 
Wolfgang  (2003) found that the consumption of a Red Bull
®
 did not raise the subjects’ 
heart rates, which was attributed to the equilibrium produced from Taurine. 
Other ingredients commonly found in energy and sports drinks include 
carbohydrate-electrolyte compounds (Amendola et al., 2004; Kotke & Gehrke, 2008). 
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The purpose of the carbohydrate-electrolyte compound is to provide a boost of energy to 
muscles and improve performance (Amendola et al., 2004). There are 14 common 
nutritional factors in these compounds including calories, total carbohydrates, sugars, 
sodium, potassium, magnesium, vitamin C, vitamin A, vitamin E, niacin, vitamin B12, 
pantothenic acid, and thiamine (Amendola et al., 2004).  
The electrolytes found in sports and energy beverages are sodium, potassium, and 
magnesium, all of which are lost through perspiration (Amendola et al., 2004). The 
metabolic heat that is produced when the body is under stress is shown to be lost by 
radiation, conduction, convection and vaporization of water, where evaporation accounts 
for 80% of metabolic heat loss (American Dietetic Association, 2000).  In addition to 
water, sweat also contains substantial amounts of sodium, modest amounts of potassium, 
and small amounts of minerals such as iron and calcium  (American Dietetic Association, 
2000). The benefits of adding sodium to a beverage are outlined by Amendola et al., 
(2004) who stated that sodium plays a key role in the body’s ability to ingest fluid, retain 
water, and replenish lost nutrients. The benefits of potassium and magnesium in 
beverages are as a supplement, which helps prevent the body from cramping to maintain 
optimum muscle performance (Amendola et al., 2004).  
Amendola et al. (2004) claim the vitamins in the beverages are beneficial for 
energy production and protein metabolism. The vitamins in sports and energy beverages 
are most beneficial when the vitamins are not produced naturally to a sufficient level, 
typically at times when the body is under increased mental and physical stress (Amendola 
et al., 2004). When the body is under increased mental and physical stress, it may show 
sub-optimal metabolism and decreased performance (Amendola et al., 2004). Vitamins 
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and minerals are also related to the repair function of the body (American Dietetic 
Association, 2000). Stresses on the body affect the metabolic pathways, which increase 
micronutrient needs (American Dietetic Association, 2000).  
B vitamins are also commonly found in high doses in energy beverages 
(American Dietetic Association, 2000). The American Dietetic Association (2000) states 
that B vitamins have two major functions: the production of energy and the regulation 
and production of red blood cells for protein synthesis and tissue repair. Vitamins A, E, 
and C, beta-carotene, and selenium help protect the body against oxidative damage 
(American Dietetic Association, 2000). At times of elevated mental and physical stress, 
oxygen requirements can increase by 10 -15 times; therefore, the body requires large 
amounts of B vitamins to handle the stress placed on it (American Dietetic Association, 
2000). 
Effects of energy beverages.  The effects of the ingredients found in energy 
drinks have been  increased cognitive performance, alertness, mood, and mental 
performance (Deixelberger-Fritz et al., 2003). In a study by Deixelberger-Fritz et al. 
(2003), the energy drink, Red Bull
®
, was evaluated. Thirty-two subjects were subjected to 
a mental performance test after consuming the energy beverage. The participants 
included 24 pilots and 8 non-pilots. The results demonstrated “clear-cut positive effects 
of the energy drink on choice reaction time and on the performance in a concentration 
test,” at a .05 significance level (Deixelberger-Fritz et al., 2003, p.23). Deixelberger-Fritz 
et al. (2003) found that the positive effects were sustained for two hours post-
consumption and do not coincide with research based on the consumption of just 
caffeine. Therefore, Deixelberger-Fritz et al. (2003) concluded that the effects are 
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produced by the cocktail of ingredients found in the energy beverage. The study by 
Deixelberger-Fritz et al. (2003) allowed for a wash period of 24 hours to avoid potential 
residual effects; however, it was noted that performance was still increased by the pilots 
on the second day, which was potentially due to a learning effect. 
In another study utilizing energy drinks by Gershon et al. (2009), Red Bull
®
 was 
evaluated in a driving simulator scenario to counteract fatigue, and the results produced 
positive effects. The results showed that the consumption of the energy beverage prior to 
completing a simulated driving task increased subject alertness (Gershon et al., 2009). 
The findings by Gershon et al. (2009) suggested that the absorption of caffeine reaches its 
maximal blood levels between 30-45 minutes post-consumption. The quick metabolism 
of energy beverages is endorsed in a further study by Brain Research (2010) on energy 
beverages consumed by sprinters and cyclists. In this study, Brain Research (2010) 
claimed that energy beverages take an almost immediate effect, due to a neural pathway 
connecting the tongue to muscles. Brain Research (2010) stated that the participants had a 
30% increased neural response following the consumption of an energy beverage 
compared to the placebo.  
There were further positive effects found from consuming an energy beverage as 
a countermeasure to fatigue, following another driving scenario-based study by Reyner 
and Horne (2002).  Reyner and Horne (2002) concluded that the consumption of an 
energy beverage was beneficial in reducing sleep-related incidents and improved 
subjective concentration. The responsible agents were identified as caffeine and Taurine 
in combination (Reyner & Horne, 2002).  
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A study testing night-shift workers, completed by Jay, Petrilli, Ferguson, Dawson, 
and Lamond (2006), attempted to establish if there were negative residual effects on 
subsequent sleep post-consumption of an energy beverage. Jay et al. (2006) concluded  
that the consumption of an energy beverage helped the participants' ability to stay alert, 
and did not affect the participants' ability to achieve a slow-wave sleep, compared to a 
control group. Additionally, sleep-onset latency was not affected. 
Two separate studies were conducted by Scholey and Kennedy (2004) and Smit 
and Rogers (2002) on mental performance, cognitive, and physiological effects following 
the consumption of an energy beverage. Smit and Rodgers (2002) discovered that the 
subjects who consumed energy beverages displayed clear-cut positive results on mood 
and reaction times. The results showed that there were “energizing, alerting and 
revitalizing effects of the two test beverages compared to water” (Smit & Rodgers, 2002, 
p. 9). These effects were reported to have lasted the duration of the test session, 100 
minutes (Smit & Rodgers, 2002). Smit and Rodgers (2002) also reported that the effects 
were present in the participants on an average of 38 minutes post-consumption. 
 Similarly, Scholey and Kennedy (2004) stated that the subjects demonstrated 
improved cognitive performance following the consumption of an energy drink.  The 
results showed that, in comparison to the placebo, there were improvements in secondary 
memory and speed of attention among the subjects (Scholey & Kennedy, 2004). Under 
all testing conditions, Scholey and Kennedy (2004) revealed a net improvement in 
performance. The study's secondary conclusion stated that the cognition-enhancing 
properties of the energy beverage cannot be solely attributed to the caffeine, but more 
likely a combination of all of the ingredients (Scholey & Kennedy 2004). 
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Normobaric High Altitude Lab   
The normobaric HAL is a beneficial tool for pilot training, and as such, the FAA 
recognizes it as a training instrument for improving pilot safety (CAT, 2009). The HAL 
enables a person to experience the effects of a simulated altitude environment without the 
need for decompression, as necessary with a hypobaric chamber (CAT, 2009).  
A hypobaric chamber reduces the pressure within it to simulate the environment 
of the standard atmosphere at an elevated altitude (CAT, 2009). As a result, the chambers 
are often small and are costly to operate due to the pressure requirements. One negative 
of hypobaric chambers is that the subjects are at risk of decompression sickness, and 
cannot return to work or fly for several hours after testing (CAT, 2009). 
 As an alternative to the hypobaric chamber, the normobaric HAL is often a 
preferable instrument for training, as pilots are able to return to work immediately 
without risk of developing decompression sickness, as it retains the same barometric 
pressure as sea-level (CAT, 2009). Another alternative to the HAL is the Hypoxic Mask-
Based system (Self, Mandella, Prinzo, Forster, & Shaffstall, 2010).  The mask-based-
system is a portable device that enables the user to experience a hypoxic environment 
through breathing gas with reduced oxygen and increased nitrogen (Self et al., 2010). The 
mask has limited side effects, allowing the user to fly almost immediately afterward (Self 
et al., 2010). However, some research questions the reliability of the mask as it can affect 
the subjects' breathing pattern (Self et al., 2010).   
The normobaric HAL was a concept designed by Professor Glen Harmon at 
ERAU and to date remains one of a handful in the world (CAT, 2009). The normobaric 
HAL uses oxygen scrubbers to remove oxygen from the atmosphere within the lab and 
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can simulate up to 30,000 feet MSL without a change in pressure (CAT, 2009). Harmon 
states that symptoms observed in the HAL can include “tunnel vision, dizziness, tingling, 
fatigue, and loss of coordination;” therefore, the lab is used to help train pilots to 
recognize how they are individually affected by a hypoxic environment (CAT, 2009). 
Frasca International Mentor Advanced Aviation Training Device 
The Frasca International Mentor Advanced Aviation Training Device (AATD) is 
an FAA-endorsed fixed position flight simulator (Frasca, 2011). It allows pilots to 
experience a glass-cockpit flight arrangement (Frasca, 2011). The Mentor is specifically 
designed to allow pilots an opportunity to fly aircraft with advanced avionics equipment 
such as the Garmin G1000 suite (Frasca, 2011). The Mentor is fully programmable and 
contains a Graphical Instructor Station (GIST) allowing the researcher the ability to set 
up any number of flight procedures for the subject to complete (Frasca, 2011). The 
accuracy of the Mentor is endorsed by the FAA, specifically in terms of both the FAA-
approved AATD and the FAA-approved flight data package (Frasca, 2011).    
Pulse Oximeter 
The pulse oximeter is an important lab tool, as it allows the researcher the ability 
to test the subjects' pulse rate and SpO2% saturation levels; which, when combined, give 
the researcher an accurate reading of the subjects' blood oxygen levels (Tremper, 1989). 
The ability to read a subject's SpO2% levels and beats per minute (BPM) saturation 
levels is of great importance, as it allows the researcher to gauge whether the subject is in 
one of the four levels of hypoxia as defined by Darwish, (2003). This is pertinent to both 
the study and the safety of the subject. The HAL utilizes the Nonin fingertip pulse-
oximeter to provide fast and accurate blood oxygen level readings (Nonin, 2011). The 
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accuracy of the Nonin Onyx used in the HAL was endorsed by achieving a U.S. Army 
and U.S. Air Force aero-medical certification (Nonin, 2011). Nonin (2011) states: 
The Onyx is ideal for use in any situation where a fast and accurate reading of 
blood oxygen saturation and pulse rate is needed. Never search for a pulse 
oximeter or sensor again. The portability and functionality of the Onyx makes it a 
valuable tool in any situation where a fast and accurate reading of blood oxygen 
saturation and pulse rate is needed. (p. 19) 
Summary 
Part 91, the General Operating and Flight Rule (2010), states that in an un-
pressurized cabin a pilot may only fly between 12,500 feet MSL and 14,000 feet MSL for 
a maximum of 30 minutes without supplemental oxygen. The General Operating and 
Flight Rule (2010) also states that, at altitudes above 14,000 feet MSL, the flight crew 
must be provided with and use supplemental oxygen; and at altitudes above 15,000 feet 
MSL, every occupant must be provided with supplemental oxygen. 
Part 121, the Supplemental Oxygen: Reciprocating Engine Powered Airplane Rule 
(2010), states that in an unpressurized cabin, supplemental oxygen must be provided if 
operating at altitudes above 10,000 feet MSL, up to and including 12,000 feet MSL for 
more than 30 minutes. Part 121, the Supplemental Oxygen: Reciprocating Engine 
Powered Airplane Rule (2010), also states that above 12,000 feet MSL each member of 
the flight crew must be provided and use supplemental oxygen for the entire flight. Under 
Part 135, the Pilots Requirements Rule: Use of Oxygen (2010), states that in 
unpressurized aircraft, oxygen must be used at altitudes above 10,000 feet MSL through 
12,000 feet MSL if that part of the flight exceeds more than 30 minutes duration; and at 
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all times above 12,000 feet MSL. The FAA (2011) states that deterioration in night vision 
occurs at altitudes as low as 5,000 feet MSL. The FAA (2011) also states that in normal 
healthy pilots at altitudes of 12,000 feet MSL and above, judgment, memory, alertness, 
and coordination can be impaired. From 12,000 feet MSL and 15,000 feet MSL, pilots 
may also experience drowsiness, dizziness, and euphoria (FAA, 2011). Darwish (2003) 
states that there are levels of severity in hypoxia, and that human beings have individual 
tolerance levels to a low-altitude hypoxic environment, which can be dependent on their 
condition of health.  
Energy beverages have proven to be stimulants, which suggests they may have an 
effect on pilot performance, and may affect the symptoms found from experiencing a 
hypoxic environment. Caffeine is recognized as being the main active ingredient in 
energy beverages and can improve alertness, mental function and efficiency in vigilance 
tasks (Kotke & Gehrke, 2008). Taurine has been observed to actively lower the heart rate 
and stabilize the body’s noradrenalin concentration in times of elevated mental and 
physical stress (Gershon et al., 2009). The American Dietetic Association (2000) states 
that B-vitamins assist in the body’s production of energy and the regulation and 
production of red blood cells. Therefore, in high doses similar to the levels found in 
energy beverages, B-vitamins will increase the body’s efficiency in the absorption of 
oxygen in times of elevated physical and mental stress (American Dietetic Association, 
2000).   
The Normobaric HAL provides a safe, accurate environment for the subjects to be 
tested in, without the possibility of decompression sickness (CAT, 2009). The Frasca 
International Mentor AATD  is specifically designed to allow pilots an opportunity to fly 
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a GA aircraft with advanced avionics equipment, and allows the operator the capability to 
program flight tasks for test purposes (Frasca, 2011). The accuracy of the Mentor AATD 
was tested by the FAA, and is approved for use as a pilot training device (Frasca, 2011). 
The pulse oximeter meets standards for use by the U.S. Army and Air Force (Nonin, 
2011).  
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Chapter III 
Methodology 
Research Approach 
The study was an experimental design that analyzed the effects of two energy 
beverages plus one placebo beverage against the effects of hypoxia in a group of eleven 
subjects. The study included comparative research to evaluate and analyze the subjects' 
ability to fly a standard simulated instrument approach based on the variables: vertical 
deviations from Glide-Slope (GS), lateral deviations from localizer, and deviations from 
the prescribed speed of 100 knots. The subjects were always at a simulated altitude where 
oxygen deprivation was present to a level that represented 14,000 feet MSL. 
The study aimed to evaluate whether the energy beverages could decrease the 
effects of hypoxia, and change the subjects' tolerances to its effects. The altitude 
remained the same for all subjects; the independent variables were the energy beverages. 
The study was conducted within the HAL. The data was collected from the outputs of the 
Frasca International Mentor (AATD) (Frasca, 2011). The subjects were asked to conduct 
a simulated standard instrument approach in a typical GA aircraft. 
The stimulant beverages contain the following common ingredients: 
• Caffeine - The most common ingredient; it stimulates the central nervous 
system giving the body a sense of alertness. It can raise the heart rate to 
deliver more oxygen around the body (Kotke & Gehrke, 2008). 
• Taurine - It helps regulate heartbeat, muscle contractions, and regulate                            
energy levels (Kotke & Gehrke, 2008). 
• Guarana – It increases alertness and energy (Kotke & Gehrke, 2008). 
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• B Vitamins – They help with converting food into energy, and improving 
the body's ability to intake oxygen into the blood (American Dietetic 
Association, 2000). 
• Sugars – They fuel the body and increase energy (American Dietetic 
Association, 2000) 
•      The placebo was a naturally flavored carbonated water and had no active 
ingredients or stimulants of any kind.  
Design and procedures. The experiment was fully outlined and submitted to the 
Institutional Review Board (IRB), where approval was required due to the use of human 
subjects in the experimentations (IRB Forum, 2011). Appendix A contains the IRB 
documentation. Upon approval, the research was advertised to participants on a first-
come, first-served basis. The respondents to the advertisement were all male. The 
subjects were subsequently invited to an information presentation where they were 
informed of all the possible ingredients found in the energy beverages and the potential 
side effects of consuming the beverages. In addition, the subjects were provided with 
information about the effects of testing in a reduced-oxygen environment. By providing 
the subjects with the potential threats and requirements to participate, the researcher had 
an opportunity to screen the participants and disqualify any subjects who could not 
tolerate this type of testing. One subject did not qualify. In addition to pre testing, the 
subjects were given a briefing on the AATD (Frasca, 2011) and the tasks that they were 
required to perform. The subjects were split into groups and each attended three lab 
sessions on different days with a minimum 24-hour interval between tests. 
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Prior to the test, several pre-test sessions were completed by the researchers who 
conducted the experiment. The pre-test sessions enabled a set of procedures to be created, 
outlining all of the variables for each scenario and a timetable of the subjects' arrival 
times. The pre test session allowed the researchers to become proficient in the operation 
of the Mentor AATD and identified the test variables. Appendix D contains the HAL 
setup procedures. 
The final test design required one researcher to be in the HAL at all times, one 
researcher to be directly outside the HAL, and one researcher to be in a pre-briefing 
room. The purpose of the researcher in the HAL was to operate the Mentor and to ensure 
the safety of the participants at all times. The researcher located directly outside the HAL 
was in charge of time management, monitoring the HAL instruments, and administering 
the pulse-oximeter tests before the subjects entered the HAL and upon exit from the 
HAL. The researcher in the briefing room was in charge of meeting and greeting the 
subjects, administering the beverages, managing time for the test sessions and ensuring 
they were qualified for testing. Qualification for testing was completed by the researcher, 
by ensuring that the subjects correctly completed the Pre Test Survey, the High Altitude 
Laboratory Participation Form, and the Medical Clearance Form. Appendix C contains 
these forms. The beverages were administered in the order of Red Bull
®
, Monster
®
, and 
then placebo, for each subject to coincide with test, 1, 2, 3. The approach plates tested 
were randomized to ensure no two subjects tested on the same approach plate 
consecutively. The subjects were always blind to which beverage they had consumed. 
Apparatus and materials. The HAL was used as the main apparatus for 
manipulating the altitude. Housed within the HAL, the Mentor AATD was used to 
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conduct the evaluation of a simulated flight task. The data was collected and stored on 
USB storage devices for security.  
The HAL incorporated recording devices, including video cameras, to record the 
data. The researcher and the subjects in the HAL had access to oxygen in the event of an 
emergency.  
Two energy beverages containing common active ingredients were used. A full 
list of the active ingredients can be found in Appendix B.  The energy beverages were 
contained in unmarked, unidentifiable, sterile containers. The researcher required the 
subjects to sign that they had been correctly briefed before the test and that they would 
adhere to the rules and procedures of the test.  
Instrument Pre Test 
The researchers conducted a satisfactory pre test for all instruments utilized in the 
experiment. The pre test enabled the researchers to recommend whether the instruments 
met the needs of the experiment and to design a set of procedures for each scenario. The 
test results were monitored and approved by advising professors, who double-checked for 
accuracy and screened for unforeseen anomalies. 
Subjects 
For the purpose of this study, the experimental sample consisted of students from 
Embry-Riddle Aeronautical University, Daytona Beach, Florida Campus. The students in 
the sample all held a minimum of a FAA class II medical certificate and a certificated 
pilot’s license with instrument rating. 
 The sample of students were self-selected as respondents to advertisements 
within Embry Riddle Aeronautical University. This method of self-selection had been 
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identified as being appropriate, as the subjects have no influence on this type of study, 
providing they met the outlined requirements. There were 11 qualified students who 
volunteered, and they were tested over the course of eight sessions, which were 
completed over one week.  
Sources of the Data 
An initial set of data was collected from the pre-test survey. The survey data 
included questions on demographics and subjects’ habits. The survey data was collected 
to enable the researcher to decide whether the subject qualified for testing. The survey 
questions are found in Appendix B.  
 Test data was obtained from the output files produced by the Mentor Advanced 
AATD. The AATD recorded multiple outputs; however, for the purpose of this 
experiment, the researcher collected data on deviation from glide slope (dots), deviation 
from localizer (feet MSL) and deviation from target speed (knots). Analysis was 
calculated based on the means of each variable. 
 Further data was collected for descriptive purposes from the subject’s pulse 
beats-per-minute (BPM), and blood oxygen levels (SpO2%) . The subjects were asked to 
provide a pulse-oximeter reading before entering the HAL and upon exit from the HAL.  
Instrument reliability.  The instruments were selected to be accurate measures of 
the tested variables. However, there were limitations in HAL control software, as the 
altitude is accurate to within +/- 300 feet MSL (CAT, 2009). The typical figures relating 
to the most common pulse oximeter instruments are ± 2 BPM or ± 2% blood oxygen 
levels (Nonin, 2011). The Mentor AATD was rated for accuracy by the FAA and was 
regarded as an accurate representation of a true-to-life flight task (Frasca, 2011). The 
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survey was utilized to validate the procedures and rules surrounding testing and to 
qualify/disqualify subjects, based on the predetermined rules. 
Instrument validity.  To maintain validity, all tests were administered in the 
same way, following the same time schedule. The instruments were calibrated before 
testing, and a pre test was conducted by the researchers. At all times, two or more 
researchers managed the proceedings by providing cross-checks. All subjects spent the 
same maximum amount of time in the HAL, as synchronized by all researchers. All 
subjects drank the same quantity of each of the beverages. The beverages were 
administered at exactly the same time before entering the HAL for all subjects in all tests.  
The pre test survey was completed as fairly as possible and required honesty from the 
subjects.   
Treatment of the Data 
Descriptive statistics. For the pre-test survey,  Questions 1, 4, 6, 10, 12 and 14 
were nominal data and were described by figures. Questions 5, 7 and 15 of the survey 
used the Likert scale and were regarded as interval data; therefore they were described in 
bar graphs. Questions 8, 9, 13, 16 and 17 were ordinal data and described by figures. 
Questions 2, 11 and 19 were interval data and were described in tables containing mean, 
standard deviation, minimum, maximum, and count. Questions 3, 18 and 20 required 
either a 100% answer or 0 answer and were described by statements. 
The pulse-oximeter output variables were pulse rate (BPM) and oxygen saturation 
levels (SpO2%) and were regarded as ratio data which were described in tables 
containing the mean, standard deviation, minimum, maximum, and count.  
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Data outputs from the Mentor AATD were the variables: deviation from glide 
slope, deviation from localizer, and deviation from target speed for each subject and for 
each beverage. Deviations were ratio data and were described in tables containing mean, 
standard deviation, minimum, maximum, and count.  
Hypothesis testing. The data from the Mentor AATD was checked at the source 
for errors. The data was manipulated into samples for each variable for each subject. The 
evaluated data were made of the previous two minutes leading up to decision height, for 
each of the variables and for each participant’s three tests. The Mentor AATD produced 
one data output per second (Frasca, 2011). The variables were categorized by beverages 
1, 2 and 3, and by approach plates 1, 2, and 3. These are summarized in Appendix E.  The 
means were calculated for each variable for each category. A repeated-measures-
ANOVA was calculated for each variable, analyzing each of the beverages, and each of 
the approach plates against each other to test for significance. 
Pilot Study  
The experiment was conducted as a pilot study and will enable further research to 
be completed in the HAL concerning this subject. This pilot study investigated the 
feasibility of conducting a future project with a larger population. 
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Chapter IV 
Results 
Descriptive Statistics – Pre-Test Questionnaire 
Eleven students from Embry Riddle Aeronautical University were given a pre-test 
questionnaire before entering the HAL.  Figure 1 describes the response to Question 1: 
Have you ever been in the HAL or other similar lab? 
 
 
Figure 1. Question #1. 
 
Table 2 describes the response to Question 2: How many times have you been in 
the Lab? 
 
Table 2 
Descriptive Statistics for Question 2 
  
Mean SD Min  Max  N 
2.2 1.3 0 3 11 
 
 
 
8 
73% 
3 
27% 
Yes
No
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Question 3: Are you a pilot? One-hundred percent answered yes, validating the 
requirement. 
Figure 2 describes the response to Question 4: What is your highest pilot 
certification or rating? (PP = Private Pilot, COM = Commercial Pilot, CME = 
Commercial Multi Engine, CFI = Certified Flight Instructor) 
 
 
Figure 2. Question #4. 
 
Figure 3 describes the response to Question 5: I am anxious about my HAL 
experience today. 
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Figure 3. Question #5. Note. Each subject responded three separate times to this question. 
 
 
Figure 4 describes the response to Question 6: I maintained a balanced diet within 
the last 24 hours 
 
 
Figure 4. Question #6. Note. Each subject responded three separate times to this question. 
 
Figure 5 describes the response to Question 7: I typically drink caffeine-based 
products and/or energy drinks 
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Figure 5. Question #7. 
 
Figure 6 describes the response to Question 8: When was your last caffeine-based 
product and/or energy drink? 
 
 
Figure 6. Question #8. Note. Each subject responded three separate times to this question. 
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Figure 7 describes the response to Question 9: When was your last meal? 
 
 
Figure 7. Question #9. Note. Each subject responded three separate times to this question. 
 
Figure 8 describes the response to Question 10: I got 8 hours or more of sleep last 
night. 
 
 
Figure 8. Question #10. Note. Each subject responded three separate times to this 
question. 
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Table 3 describes the response to Question 11: Within the last 7 days, how many 
nights did you sleep for 8 hours or more? 
 
Table 3 
Descriptive Statistics for Question 11 
 
Mean SD Min Max N 
4.1 2.9 0 7 33 
Note: Each subject responded three separate times to this question. 
 
 
 
Figure 9 describes the response to Question 12: I typically get 8 hours or more of 
sleep nightly. 
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Figure 9. Question #12. 
 
 
 
Figure 10 describes the response to Question 13: How much sleep did you get 
within the last 24 hours? 
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Figure 10. Question #13.  Note. Each subject responded three separate times to this 
question. 
 
Figure 11 describes the response to Question 14: I exercised 30 minutes or more within 
the last 24 hours. 
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Figure 11. Question #14. Note. Each subject responded three separate times to this 
question. 
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Figure 12 describes the response to Question 15: I typically exercise for at least 
30 minutes, three separate times, weekly. 
 
 
Figure 12. Question #15. Note. Each subject responded three separate times to this 
question. 
 
 
Figure 13 describes the response to Question 16: When did you last exercise? 
 
 
Figure 13. Question #16. Note. Each subject responded three separate times to this 
question. 
0              
0% 
3           
9.1% 0              
0% 
 30      
90.9% 
0               
0% 
0
5
10
15
20
25
30
35
Strongly
Disagree
Disagree Neutral Agree Strongly
Agree
1                       
3% 0                      
0% 
0                      
0% 
10                    
30.3% 
13                 
39.4% 
9                 
27.3% 
0
2
4
6
8
10
12
14
0-6
HrsAgo
07-12
Hrs ago
13-18
Hrs Ago
19-24
hrs Ago
25-36
hrs Ago
37 Hrs+
Ago
43 
 
Figure 14 describes the response to Question 17: How long did you last exercise 
for? 
 
 
Figure 14. Question #17. Note. Each subject responded three separate times to this 
question. 
 
 
For Question 18: How many alcoholic drinks have you consumed within 24 
hours? All subjects answered zero, validating the requirement. 
Table 4 describes the response to Question 19: How many alcoholic drinks have 
you consumed within the last 7 days? 
 
Table 4 
Descriptive Statistics for Question 19 
 
Mean SD Min  Max  N 
3.4 4.6 0 14 33 
Note: each subject responded three separate times to this question. 
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For Question 20: Do you smoke tobacco? One-hundred percent of the participants 
responded “no,” thus validating the requirement.  
Descriptive Statistics – Pulse Oximeter Readings 
Eleven students from Embry-Riddle Aeronautical University gave pre-test and 
post-test Pulse-Oximeter readings that were recorded before entering the HAL and upon 
leaving the HAL. Table 5 depicts the Pulse-BPM results. 
 
Table 5 
Descriptive Statistics for Pre/Post-Test BPM Recordings 
 
 
Mean SD Max Min N 
Red Bull
®
 BPM Before Test 78.0 19.1 113 53 11 
 BPM After Test 93.4 18.2 125 69 11 
 BPM Change  15.4 19.3 61 -6 11 
 Test Duration (Min) 22.2 2.8 27 19 11 
Monster
®
 BPM Before Test 91.2 18.7 118 64 11 
 BPM After Test 106.2 10.3 129 94 11 
 BPM Change  15.0 13.5 34 -10 11 
 Test Duration (Min) 19.4 2.1 24 15 11 
Placebo BPM Before Test 75.9 11.8 100 61 11 
 BPM After Test 99.3 15.2 118 78 11 
 BPM Change  23.4 14.0 52 0 11 
 Test Duration (Min) 19.2 2.5 25 15 11 
 
 
 
Table 6 depicts the Oximeter - SpO2 results. 
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Table 6 
Descriptive Statistics for Pre/Post-Test %SpO2 Recordings 
 
 
Mean SD Max Min N 
Red Bull
®
 %SpO2 Before Test   98.64    1.03  100 97 11 
 %SpO2 After Test   87.00    3.52  94 82 11 
 %SpO2 Change  - 11.64    3.47  -6 -17 11 
 Test Duration (Min)   22.18    2.79  27 19 11 
Monster
®
 %SpO2 Before Test   98.73    1.19  100 97 11 
 %SpO2 Test   89.00    5.06  98 81 11 
 %SpO2 Change  -   9.73    4.58  -1 -16 11 
 Test Duration (Min)   19.36    2.11  24 15 11 
Placebo %SpO2 Before Test   97.91    0.83  99 96 11 
 %SpO2 After Test   86.36    4.65  93 79 11 
 %SpO2 Change  - 11.55    4.76  -5 -19 11 
 Test Duration (Min)   19.18    2.52  25 15 11 
 
 
 
Descriptive Statistics – AATD Performance Output  
Eleven students from Embry Riddle Aeronautical University completed three 
simulated flight tasks within the HAL, using the Frasca International Mentor AATD. The 
flight tasks were simulated Instrument landing System (ILS) approaches at Gainesville, 
Jacksonville or St. Augustine. The researcher derived three test variables from core 
outputs of the AATD: (a) lateral deviations from localizer in dots (one dot equals 2 
degrees) (FAA, 2011), (b) vertical deviations from Glide Slope (GS) in feet MSL, and (c) 
indicated airspeed (IAS) deviations from target speed of 100 knots. Table 7 describes the 
results.  
 
 
 
 
46 
 
Table 7 
Descriptive Statistics Displaying AATD Outputs for Gainesville, Jacksonville, or St. 
Augustine 
 
  
Mean SD Min Max N 
Gainesville Localizer 
Deviations 0.68 0.47 0.20 1.67 11 
GS 
Deviations 27.22 19.50 11.59 71.87 11 
IAS 
Deviations 2.46 1.08 1.32 4.64 11 
Jacksonville Localizer 
Deviations 0.50 0.29 0.18 1.17 11 
GS 
Deviations 53.35 104.67 8.06 366.44 11 
IAS 
Deviations 3.61 4.15 0.74 15.34 11 
St Augustine Localizer 
Deviations 0.53 0.33 0.18 1.02 11 
GS 
Deviations 56.96 104.18 8.99 366.44 11 
IAS 
Deviations 2.16 1.12 0.86 4.24 11 
 
 
Eleven students from Embry Riddle Aeronautical University completed three 
simulated flight tasks within the HAL, using the Frasca International Mentor AATD. The 
flight tasks were completed after consuming Red Bull
®
, Monster
®
, or a placebo beverage. 
The researcher derived three test variables from core outputs of the AATD: Lateral 
deviations from localizer in dots (one dot equals 2 degrees) (FAA, 2011); vertical 
deviations from (GS) in feet MSL; and indicated airspeed (IAS) deviations from target 
speed of 100 knots. Table 8 describes the results. 
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Table 8 
Descriptive Statistics Displaying AATD Outputs for Red Bull
®
, Monster
®
, or a Placebo 
 
 
Mean SD Min Max N 
Red Bull
®
 Localizer 
Deviations 0.69 0.45 0.28 1.67 11 
GS 
Deviations 92.49 136.45 13.70 366.44 11 
IAS 
Deviations 3.43 4.05 1.00 15.34 11 
Monster
®
 Localizer 
Deviations 0.50 0.27 0.18 1.02 11 
GS 
Deviations 24.49 18.51 8.99 72.34 11 
IAS 
Deviations 2.61 1.10 1.02 4.44 11 
Placebo Localizer 
Deviations 0.52 0.36 0.19 1.17 11 
GS 
Deviations 20.55 14.43 8.06 52.12 11 
IAS 
Deviations 2.19 1.56 0.74 5.47 11 
 
 
 
Hypothesis Testing 
 Approach plate related to simulated flight task performance. A Repeated-
Measures-ANOVA was calculated to test the null hypothesis – There will be no 
differences in simulated flight task performance variables (Localizer deviation, Glide-
Slope deviation, and Indicated Airspeed deviation) among the approaches selected by 
random design at a constant 14,000 feet MSL. Tables 9, 10, and 11 show the results. For 
all three measures of performance in the AATD, there were no differences for the 
randomized approaches. Therefore, the repeated-measures ANOVA failed to reject the 
null hypothesis.  
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Table 9 
Repeated-Measures ANOVA Comparing Localizer Deviation Between Approaches 
 
 
Mean Std. Deviation N 
Localizer Deviation Gainesville .682 .471 11 
Localizer Deviation Jacksonville .502 .293 11 
Localizer Deviation St Augustine .529 .327 11 
Effect Value F 
Hypothesis 
df 
Error 
df Sig. 
Partial 
Eta 
Squared 
Localizer
Deviation 
Pillai's 
Trace 
.190 1.055
a
 2.000 9.000 .388 .190 
Wilks' 
Lambda 
.810 1.055
a
 2.000 9.000 .388 .190 
Hotelling's 
Trace 
.234 1.055
a
 2.000 9.000 .388 .190 
Roy's 
Largest 
Root 
.234 1.055
a
 2.000 9.000 .388 .190 
a. Exact statistic 
 
 
Table 10 
Repeated-Measures ANOVA Comparing Glide-Slope Deviation Between Approaches  
 
 
Mean Std. Deviation N 
Glide-Slope Deviation Gainesville 27.217 19.496 11 
Glide-Slope Deviation Jacksonville 53.354 104.668 11 
Glide-Slope Deviation St Augustine 56.964 104.183 11 
Effect Value F 
Hypothesis 
df 
Error 
df Sig. 
Partial 
Eta 
Squared 
Glide-Slope 
Deviations 
Pillai's 
Trace 
.172 .935
a
 2.000 9.000 .427 .172 
Wilks' 
Lambda 
.828 .935
a
 2.000 9.000 .427 .172 
Hotelling'
s Trace 
.208 .935
a
 2.000 9.000 .427 .172 
Roy's 
Largest 
Root 
.208 .935
a
 2.000 9.000 .427 .172 
a. Exact statistic 
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Table 11 
Repeated-Measures ANOVA Comparing Indicated Airspeed Deviation Between 
Approaches 
 
 Mean 
Std. 
Deviation N 
Indicated Airspeed Deviations Gainesville 2.460 1.076 11 
Indicated Airspeed Deviations Jacksonville 3.610 4.150 11 
Indicated Airspeed Deviations St Augustine 2.169 1.120 11 
Effect Value F 
Hypothesis 
df 
Error 
df Sig. 
Partial 
Eta 
Squared 
Indicated 
Airspeed 
Deviations 
Pillai's 
Trace 
0.25 1.497
a
 2.00 9.00 0.27 0.25 
Wilks' 
Lambda 
0.75 1.497
a
 2.00 9.00 0.27 0.25 
Hotelling's 
Trace 
0.33 1.497
a
 2.00 9.00 0.27 0.25 
Roy's 
Largest 
Root 
0.33 1.497
a
 2.00 9.00 0.27 0.25 
a. Exact statistic 
 
 
Energy beverage related to simulated flight task performance.  A Repeated-
Measures-ANOVA was calculated to test the null hypothesis – There will be no 
differences in simulated flight task performance variables (Localizer deviation, Glide-
Slope deviation, and Indicated Airspeed deviation) among the energy beverages selected 
by specified design at a constant 14,000 feet MSL. Tables 12, 13, and 14 show the 
results. For all three measures of performance in the AATD, there were no differences for 
the specified beverage. Therefore, the repeated-measures-ANOVA failed to reject the 
null hypothesis.  
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Table 12 
Repeated-Measures ANOVA Comparing Localizer Deviation Between Beverages 
 
 
Mean Std. Deviation N 
Localizer Deviation Red Bull
®
 .692 .452 11 
Localizer Deviation Monster
®
 .504 .274 11 
Localizer Deviation Placebo .517 .3622 11 
Effect Value F 
Hypothesis 
df 
Error 
df Sig. 
Partial Eta 
Squared 
Localizer 
Deviation 
Pillai's 
Trace 
.190 1.056
a
 2.000 9.000 .387 .190 
Wilks' 
Lambda 
.810 1.056
a
 2.000 9.000 .387 .190 
Hotelling's 
Trace 
.235 1.056
a
 2.000 9.000 .387 .190 
Roy's 
Largest 
Root 
.235 1.056
a
 2.000 9.000 .387 .190 
a. Exact statistic 
 
 
Table 13 
Repeated-Measures-ANOVA Comparing Glide-Slope Deviation Between Beverages 
 
Mean Std. Deviation N 
Glide-Slope Deviation Red Bull
®
 92.494 136.453 11 
Glide-Slope Deviation Monster
®
 24.487 18.512 11 
Glide-Slope Deviation Placebo 20.554 14.426 11 
Effect Value F 
Hypothesis 
df 
Error 
df Sig. 
Partial Eta 
Squared 
Glide-Slope  
Deviations 
Pillai's 
Trace 
.371 2.659
a
 2.000 9.000 .124 .371 
Wilks' 
Lambda 
.629 2.659
a
 2.000 9.000 .124 .371 
Hotelling's 
Trace 
.591 2.659
a
 2.000 9.000 .124 .371 
Roy's 
Largest 
Root 
.591 2.659
a
 2.000 9.000 .124 .371 
a. Exact statistic 
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Table 14 
Repeated-Measures ANOVA Comparing Indicated Airspeed Deviation Between 
Beverages 
 
 
Mean Std. Deviation N 
Indicated Airspeed Deviation Red Bull
®
 3.429 4.048 11 
Indicated Airspeed Deviation Monster
®
 2.609 1.105 11 
Indicated Airspeed Deviation Placebo 2.191 1.564 11 
Effect Value F 
Hypothesis 
df 
Error 
df Sig. 
Partial 
Eta 
Squared 
Indicated 
Airspeed 
Deviations 
Pillai's 
Trace 
.117 .597
a
 2.000 9.000 .571 .117 
Wilks' 
Lambda 
.883 .597
a
 2.000 9.000 .571 .117 
Hotelling's 
Trace 
.133 .597
a
 2.000 9.000 .571 .117 
Roy's 
Largest 
Root 
.133 .597
a
 2.000 9.000 .571 .117 
a. Exact statistic 
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Chapter V 
Discussion, Conclusions, and Recommendations 
Discussion 
This study was designed to see if there was a gain in performance by a set of 
subjects, based on the Mentor AATD output variables (lateral deviation, vertical 
deviation, and airspeed deviation), during periods of simulated low-altitude hypoxia, 
when subjects consumed different energy beverages, including a placebo. The study-
design was developed to provide an analytical pilot study that could supply evidence for a 
safety recommendation to pilots who may be exposed to conditions conducive of low-
altitude hypoxia. The population consisted of 11 male pilots who had a minimum of a 
private pilot's license with an instrument rating, and at least a second-class medical 
certificate.   
Localizer deviations.  A repeated-measures-ANOVA was calculated to evaluate 
effects of the energy beverages and the placebo beverage on subjects’ Mentor AATD 
performance outputs. The significance for localizer deviations among the averages of the 
subjects revealed (p = .387), based on Pillai’s Trace, as calculated in the repeated-
measures-ANOVA. The mean following consumption of Red Bull
®
 was .692 with a 
standard deviation of .452, which was the greatest value. The second ranked mean value 
was following consumption of the placebo with .517, and a standard deviation of .3622. 
Consumption of the Monster
®
 produced the lowest mean for lateral deviation with .504, 
and a standard deviation of .274.  
The researcher suggests that the small significance may be explained by Type 2 
error because of the small number of subjects. In addition, the researcher suggests that 
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practice effects may have affected the results. Specifically, an explanation for Red Bull
®
 
performing worst for the variable (lateral deviation) was that Red Bull
®
 was the first 
beverage all subjects consumed. Therefore, it was the first attempt for all subjects to use 
the Mentor AATD. The designed order of beverages was Red Bull
®
, Monster
®
, and then 
placebo. The mean times per test indicate that subjects performed the task quicker as they 
gained experience in the AATD. Red Bull
®
, the first test, had a mean test time of 22 
minutes and 18 seconds; Monster
®
 had a mean test time of 19 minutes and 36 seconds; 
and the placebo beverage had a mean test time of 19 minutes and 18 seconds. As the 
times decreased with the number of tests completed, the researcher suggests that the 
subjects improved in proficiency on the Mentor AATD, which may have inadvertently 
skewed results for the placebo. In addition, the subjects spent the longest time in the HAL 
on their first test, which was Red Bull
®
; therefore, the subjects had a longer exposure to 
the hypoxic environment, which possibly attributed to decreased performance. It should 
be noted that the standard deviation for the placebo was the greatest, followed by Red 
Bull
®
 and then Monster
®
. As the placebo beverage had a larger standard deviation, the 
researcher concluded that some subjects performed worse upon consuming the placebo 
beverage, based on the Mentor AATD output of lateral deviation, and compared with the 
other beverages. 
Glide-Slope deviations. The performance variable, GS deviations, had a 
significance of (p =.124) based on Pillai’s Trace, as calculated in the repeated-measures-
ANOVA. The p-value was not statistically significant; however, it was smaller than that 
seen with the performance output (lateral deviation) (p = .387).  
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The mean value for Red Bull
®
 was greatest with a value of 92.494 and a standard 
deviation of 136.453. The mean value for Monster
®
 was 24.487 with a standard deviation 
of 18.512. The placebo had a mean of 20.554 and a standard deviation of 14.426. 
The Mentor AATD output performance indicator (GS deviation) showed that the 
subjects performed best following the consumption of the placebo beverage. However, 
the researcher concluded that the results may be conflicted, as the subjects spent the 
shortest time in the HAL when completing the placebo simulated test, and would have 
been least affected by the reduced oxygen environment. In addition, the subjects were 
most practiced on the third run, which may explain why the gap between the means of the 
Monster
®
 and the placebo are small compared to the gap between Red Bull
®
 and 
Monster
®
. In addition, the researcher suggests that the small significance may be 
explained by Type 2 error, because of the small number of subjects.  
Indicated airspeed deviations.  The performance variable, indicated airspeed 
deviations, showed the least significance (p =.571) based on Pillai’s Trace, as calculated 
in the repeated-measures-ANOVA. There were no significant differences among the 
three beverages; however, trials with Red Bull
®
 continued to have higher deviations. The 
mean value for Red Bull
®
 was again greatest with a value of 3.429 and a standard 
deviation of 4.048. The mean value for Monster
®
 was 2.609 with a standard deviation of 
1.105. The placebo had a mean of 2.191 and a standard deviation of 1.564.  
The Mentor AATD output performance indicator (indicated airspeed deviation) 
again showed that the subjects performed best following the consumption of the placebo 
beverage. The lack of significance recorded is consistent with Type 2 error, which is 
common with a small test population. A pilot study is by design a method of evaluating 
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the possibility for further study through preliminary testing with a small population. The 
subjects performed worst upon consumption of a Red Bull
®
. There was again a larger gap 
between the performances recorded from the subjects' first test (Red Bull
®
), compared to 
the subjects' second test (Monster
®
). The gap recorded in performance between test two 
(Monster
®
), and test three (placebo) was minimal.  
 Pulse-Oximeter.  The test data related to the pulse-oximeter was not valid for a 
statistical analysis, as the readings were taken outside of the HAL. The readings were 
taken outside of the HAL because, if the subjects had been aware of their %SpO2 
readings during testing, they could have determined the simulated altitude. The readings 
were taken immediately before the subjects entered the HAL and immediately upon 
exiting the HAL; and as such, the descriptive statistics highlight some interesting 
observations.  
Comparing the mean changes in the subjects' heart rates upon consumption of 
each beverage, some conclusions can be drawn on the physiological effects of the 
beverages on the subjects.  The mean increase in heart rate following the consumption of 
Red Bull
®
 was 15.4 BPM; the mean increase in heart rate following the consumption of 
Monster
®
 was 15 BPM; and the mean increase in heart rate following the consumption of 
the placebo was 19.2 BPM. Therefore, the average subject's heart-rate increase was 
smallest following the consumption of Monster
®
, second was Red Bull
®
, and the greatest 
increase followed the consumption of a placebo. An explanation for this may be 
attributed to the increasing levels of Taurine found in the energy beverages compared to 
the placebo. Taurine has been shown to stabilize a human’s heartbeat when exposed to 
elevated levels of stress (Kotke & Gehrke, 2008). 
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Comparing the mean changes in the subjects' blood-oxygen levels upon 
consumption of each beverage; further conclusions can be drawn. The mean blood-
oxygen saturation change for Red Bull
®
 was -11.64 %SpO2, the mean blood-oxygen 
saturation change for Monster
®
 was -9.73 %SpO2, and the mean blood-oxygen saturation 
change for the placebo was -11.55 %SpO2. Therefore, the average change in the subjects' 
blood-oxygen saturation was smaller upon consuming the Monster
®
 energy beverage. 
The placebo and the Red Bull
®
 beverages showed close results, with the placebo having 
the least saturation. However, it is important to note that the mean time in the HAL 
during Red Bull
®
 testing was exactly three minutes longer than that of the placebo. 
Therefore, the researcher concluded that the saturation might have been smaller upon 
consumption of the Red Bull
®
 if the exposure times were equal. 
Conclusions 
The analyses of the hypothesis were not significant; however, the descriptive 
results were encouraging. The researcher concluded that there were non-significant 
differences among the performance indicators upon consumption of the energy beverages 
compared to the consumption of the placebo.  
The researcher concluded that changes in performance despite being statistically 
insignificant might be attributed to an improved concentration and a physiological change 
in the body’s ability to absorb oxygen from the air due to the large dose of active 
ingredients contained within the beverages (Kotke & Gehrke, 2008). The caffeine 
contained within the energy beverages is a central nervous system stimulant and is 
designed to improve reaction times and mental function (Reissig et al., 2008).  
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The enhanced concentration attributed to the energy beverages might have 
produced the increased performance noted in the results. In addition, the high doses of 
Taurine found in both energy beverages might have slowed the subjects' heart rates 
compared to the placebo (Amendola et al., 2004). An increased heart rate is a symptom of 
low altitude hypoxia, as noted by Darwish (2003). 
The researcher concluded that the cocktail of B-vitamins found in the energy 
beverages might have marginally improved the body's efficiency in absorbing oxygen 
from the reduced oxygen environment as reported by American Dietetic Association 
(2000). When Taurine and large doses of B-vitamins are combined, the body stabilizes 
and improves in efficiency when subjected to increased mental and physical stress. This 
is a benefit when the body is in need of more oxygen (Amendola et al., 2004; Kotke & 
Gehrke, 2008; Reissig et al., 2008). 
The researcher concluded that the Monster
®
 energy beverage had the most potent 
effects, as it has twice the active ingredients found in Red Bull
®
 (American Dietetic 
Association, 2000). The evidence supporting this statement can be seen in the results 
from the repeated-measures-ANOVA for the performance indicator, Localizer 
Deviations. The descriptive statistics from the blood-oxygen-saturation recordings 
support this statement. 
Only a small number of the aviation accidents being reported annually are 
attributed to low-altitude hypoxia. However, the potential for pilots to experience low-
altitude hypoxia is a credible danger. The researcher concluded that there was some 
supporting evidence that would support conducting further research on this subject, with 
an aim of making a safety recommendation to pilots. The researcher concluded that this 
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pilot study was affected by Type 2 error where the sample size was too small and results 
were likely impacted by practice effects. 
Recommendations 
The results obtained from the Mentor AATD and the Pulse-Oximeter are 
consistent with a pilot study and have produced encouraging signs for further research. 
Future research should have a larger population. By testing a minimum of 33 subjects, the 
results would not be subject to Type 2 error, as in this study. Typically, a minimum of 33 
subjects would have been required to achieve a 0.05 effect size. 
The researcher recommends that the design should randomize the energy 
beverages as well as the approach plates. By randomizing the energy beverages, the 
results would not show indications of a practice effect from the first beverage to the last, 
with respect to the subject's proficiency on the Mentor AATD. There was evidence 
supporting improvement from the first beverage to the second beverage. In addition, there 
was a difference in the time of exposure from the first test to the last, due to practice 
effects. 
The researcher additionally recommends that the subjects complete several pre-
test simulation approaches to enable them to have enough time to be proficient in the use 
of the Mentor AATD, thus eliminating the differences in exposure time. In addition, there 
was evidence from questionnaire question (What is your highest pilot qualification or 
rating?) that there were pilots with varied levels of experience. Further research should 
group subjects based on experience. 
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The researcher observed that the subjects spent different times consuming the 
beverages. In future research the test schedule should be designed to begin the test from 
the point of consumption and not from the time the beverage was provided.  
The researcher recommends that the pulse-oximeter readings should be used for 
analysis. The pulse-oximeter could include a wireless sensor that would send the readings 
outside of the HAL, so the subjects are never aware of the readings. The researcher also 
suggests that a greater variety of test variables be analyzed from the Mentor AATD data 
outputs. 
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Dear Cass Howell & Daniel Bull, 
  
The Chair of the IRB has reviewed the revised protocol application for the project 
titled, “Effects of Energy Beverages in Counteracting the Symptoms of Mild Hypoxia 
at General Aviation Altitudes” to see that it met with all the requirements as written in 
the Determination Form as was established at the full IRB Committee meeting.  All of 
the outstanding issues have been addressed and clearly stated in the application and 
Consent Form. 
  
You may begin your data collection.  Attached is the Revised Determination Form for 
your records.  Best of luck in your endeavors. 
  
Teri Vigneau (va new), CRA, MPA  
Human Protections Administrator 
Pre-Award Manager 
Sponsored Programs 
(386) 226-717
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Pre-test Survey 
 
 
Dear participant please complete the following pre-test survey. It is compulsory, and the 
reliability of the results is dependent on the accuracy of the answers provided. The questions are 
designed to ensure this test is completed as safely as possible. Please circle the most appropriate 
option, to the best of your ability even if it means you become exempt from testing. Another test 
session can be arranged. This questionnaire studies whether daily habits influence hypoxic 
reactions during a HAL exposure and all answers will remain confidential, Circle or fill in the 
answers as appropriate. Questions 1,2,3,4,7,12,15 and 20 are only required on the first test 
session ~Thank you. 
 
Date:              Time:           
 
HAL Experience: 
1. Have you ever been in the HAL or other similar lab?  
(Circle one) Yes    No    
 
2. How many times have you been in the Lab? 0       1        2        3        4          
 
3. Are you a pilot?  
(Circle one) Yes   No     
 
4. What is your highest pilot certification or rating?  
(Circle one)  PP        COM       CME        CFI      
 
5. I am anxious about my HAL experience today. 
 (Circle one)  Strongly Disagree     Disagree      Neutral      Agree      Strongly Agree 
 
Eating Habits: A balanced diet is 2,000 calories a day from eight servings of grains, five servings of vegetables and 
fruits, three servings of milk or dairy products, two or fewer servings of meat and beans, and three servings of 
healthy oils (US Department of Agriculture). 
6. I maintained a balanced diet within the last 24 hours.  
(Circle one)  Yes  No     
    
7. I typically drink caffeine-based products and/or energy drinks 
 (Circle one) Strongly Disagree     Disagree      Neutral      Agree     Strongly Agree 
 
8. When was your last caffeine-based product and/or energy drink * 
(Circle one) 0-12 Hrs 13-24 Hrs 25-36 Hrs 37-48 Hrs 48 Hrs+   
* Note: If you have consumed a caffeine-based product and/or energy drink within 24 hours prior to testing, 
you cannot complete the test today     
 
9. When was your last meal?**  
(Circle one)   0-2 Hrs    2-4 Hrs   4-6 Hrs    6-8 Hrs 8 Hrs+ 
**Note: If you have eaten within the past 2 hours, you cannot complete the test today   
 
Sleeping Habits: 
10. I got 8 hours or more of sleep last night.  
(Circle one) Yes   No 
 
11. Within the last 7 days, how many nights did you sleep for 8 hours or more?  
(Circle one)  0       1     2   3   4   5   6   7 
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12. I typically get 8 hours or more of sleep nightly.  
(Circle one) Yes  No      
 
13. How much sleep did you get within the last 24 hours? 
 (Circle one)  1-2 Hrs     2-3 Hrs     3-4 Hrs    4-5 Hrs     6-7 Hrs     7-8 Hrs     8 Hrs+ 
 
Exercise Habits: 
14. I exercised 30 minutes or more within the last 24 hours. (Circle one)  Yes   No 
 
15. I typically exercise for at least 30 minutes, three separate times, weekly.  
(Circle one)  Strongly Disagree      Disagree      Neutral      Agree      Strongly Agree 
 
16. When did you last exercise?  
(Circle one)  0-6 Hrs      07-12 Hrs      13-18 Hrs      19-24 hrs      25-36 hrs      37 Hrs+ 
 
17. How long did you last exercise for? 
(Circle one)  <30 Mins 31-60 Mins 61-90 Mins 91-120 Mins 120 Mins+ 
 
Drinking Habits: An alcoholic drink is defined as a 12-ounce beer, 8-ounces of malt liquor, 5-ounces of wine, or a 
1.5-ounce “shot." (US Department of Agriculture and Health) 
 
18. How many alcoholic drinks have you consumed within 24 hours?(Circle one) 
 0 1 2 3 4   5   6 7 8   9 10 10+ 
 
19. How many alcoholic drinks have you consumed within the last 7 days? (Circle one)  
 0 1 2 3 4   5   6 7 8   9 10 10+ 
 
***Note: If you have consumed an alcoholic beverage within the last 24 hours, you cannot complete the test 
today 
 
Smoking Habits: 
 
20. Do you smoke tobacco **** 
(Circle one)   Yes No  
 
**** Note: If you smoke tobacco, you cannot complete this study 
 
 
I ……………………………… declare that the answers given are 100% accurate to the best 
of my knowledge, and I understand that the questionnaire has been designed to qualify or 
eliminate me from completing the study for the protection of my own safety.  
Signed ………………………………… 
 
This concludes the questionnaire. Thank you for your time! 
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High Altitude Normobaric Lab 
Medical Screening Checklist 
 
Participation in the High Altitude Lab (HAL) is limited to ERAU faculty/ students who are: 
1. At least 18 years of age, sophomore standing  
2. Are enrolled in or have completed AS 357 Flight Physiology    
3. Hold a pilot license with an instrument rating and at least a 2nd class FAA medical 
certificate or equivalent.  
4. Have no known allergies or sensitivities to the ingredients identified in the list below 
Acacia 
Ascorbic Acid 
Aspartame 
Biloba 
Benzoate 
Berry Juice 
Fruit Juice 
Caffeine 
Calcium 
Camitne 
Camitne Fumarate 
D-ribose 
Ginkgo Biloba leaf extract 
Ginseng 
Glucose 
Glucuronolactone 
Glycerol Ester of wood rosin 
Grape seed extract 
Guarana extract 
Guarana seed 
Inositol 
L-Arginine 
L-Carnitine 
Maltodextrin 
Milk Thistle extract 
Niacinamide 
Pannax ginseng extract 
Pantothenate 
Pantothenic Acid 
Phosphorus 
Potassium 
Pyridoxine 
Riboflavin 
Sodium 
Sodium Citrate 
Sucrose 
Taurine 
Vitamin A 
Vitamin B2 
Vitamin B3 
Vitamin B5 
Vitamin B6 
Vitamin B12 
Vitamin C 
Vitamin D 
Vitamin E 
Vitamin K 
Yerba mate leaf extract 
 
Restrictions: Participation in an altitude chamber flight will not be permitted if the applicant 
1. Has a disqualifying beard (Beards are permitted if the individual can form an airtight 
oxygen mask seal.)   
2. Has donated one unit (500 ml) of blood within 24 hours of the scheduled training 
3. Is under the influence of alcohol, sedating or psychotrophic drugs, or has consumed any of 
the pre-mentioned within 24 hours prior to the test session. 
4. Has any known allergies or sensitivities to the ingredients identified in the beverages 
required to be consumed 
5. Smokes Tobacco  
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6. Has any known sensitivities to being subjected to a mildly hypoxic environment 
7. Has eaten within two hours prior to arriving for the test session 
8. Has consumed a coffee or energy based product within 24 hours prior to arriving for the 
test session 
 
Safety Considerations 
Following participation in a high altitude lab flight, the student should not fly solo or as a 
primary crewmember for a period of 12 hours.  
The use of Chap Stick®, lip-gloss, oil or Vaseline® based make-up is not permitted in the lab 
while wearing oxygen masks. 
 
Medical Screening: 
For health and safety reasons, you must notify an instructor if you are currently experiencing any 
of the symptoms or conditions below: 
 _______ Dizziness, fainting spells, unconsciousness or seizures 
 _______ Eye or vision trouble (except corrective lens) 
 _______ Heart or vascular trouble, or anemia  
 _______ Upper respiratory infection, asthma or bronchitis  
 _______ Chest pain or shortness of breath 
 _______  Diabetes 
 _______ Medications not approved for flight 
 _______  Recent surgery 
 _______ Pregnancy or you have other health concerns 
Although unlikely, in some subjects symptoms relating to being in a low oxygen environment 
may include, but not be limited to dizziness, nausea, rapid breathing, visual impairment, mental 
confusion and poor coordination. Some headaches or nausea may also occur after the normobaric 
experience any time above sea level oxygen content. If this occurs, you must tell the 
instructor/researcher and the test will be terminated. 
Despite being very rare, in some consumers the side effects of consuming the ingredients listed 
in the table above can cause dizziness, irritability, nausea, nervousness, jitters, nosebleeds, high 
blood pressure, low blood pressure, heart palpitations, breast pain, stuffy nose, restlessness and 
sleeping difficulty. Allergic reactions can include; rash, hives, itching, difficulty breathing, 
tightness in the chest, swelling of the (mouth, face, lips, or tongue), diarrhoea, shakiness, trouble 
sleeping, vomiting. Headaches and fatigue may be experienced from withdrawal. 
Note: The beverages provided are off-the-shelf, available to all Americans across all of the 
United States with no age restriction 
I have read and understand the statements above, declare that I am in good health, and agree to 
participate in the high altitude-training lab. 
_________________________________________________ _____/_____/__________  
Print Name        Date 
_______________________________________________ 
Signature 
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HIGH-ALTITUDE LABORATORY PARTICIPATION RELEASE FORM 
 
1. I, ________________________________ (name), hereby acknowledge that I will participate in the 
use of a High Altitude Laboratory (“Lab”) on the grounds of Embry-Riddle Aeronautical University 
(ERAU) in order to experience and learn about the physiological effects of unpressurized high 
altitude aviation. I understand that the effects of such experience may include, but not be limited to 
dizziness, nausea, rapid breathing, visual impairment, mental confusion and poor coordination. These 
effects are usually temporary, but since each person is different and has their own unique medical 
circumstances, I recognize that ERAU makes no representations as to how use of the Lab may affect 
me.  
 
1. I agree that I am medically and otherwise fit to participate in the use of the high-altitude laboratory, 
and that I am free to decline to participate in any activity I deem too risky, dangerous, or ill-advised. 
My use of the Lab shall be conclusive evidence that I am fit and qualified to participate therein.  
 
1. In consideration of permission to use the Lab, I hereby release, discharge, and hold harmless ERAU, 
its Trustees, Directors, officers, employees, agents, representatives, and successors in interest 
(“indemnified parties”) from any and all claims of whatever kind or nature, including serious bodily 
injury or death, for any and all claims, demands, obligations, and liabilities arising from, connected 
with, or related to my participation in or use of the laboratory or any activity or event connected 
therewith.  
 
1. I agree to defend and indemnify the indemnified parties on demand from any and all related claims, 
demands, obligations, and liabilities of whatever kind or nature. Additionally, I will not file, cause to 
be filed, participate in, permit, or cooperate with or in any action, claim, or demand against the 
indemnified parties for any act or event arising from, connected with, or related to my use of the Lab.  
 
1. Any disputes arising from, related to, or in connection with this release or the activities to which it 
pertains shall be exclusively subject to the laws, jurisdiction, and venue of the State of Florida and 
County of Volusia. I agree to resolve any disputes between me and ERAU by means of mediation 
using a mutually agreed mediator. In the event of a failure of mediation for any reason, I agree that, in 
lieu of litigation in a court of law, the dispute shall be resolved by means of binding arbitration in 
which each side shall select an arbitrator to serve on an arbitration panel, and those selectees shall 
chose a third member of the arbitration panel who shall preside. The arbitration panel shall conduct 
the arbitration in accordance with the rules of the American Arbitration Association, and its ruling 
shall be final and binding upon the parties. Any part of this agreement that is deemed void or voidable 
shall be excised from this agreement and the remaining terms shall remain in full force and effect as 
though the excised term had never been included.  
 
Signed: ______________________________________  
Participant (print): Date  
Witness:  
(Printed): Date  
 
ERAU OGC Approved  
1-030609-7/000 
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Dear participant, for the purpose of this study you will be required to consume three separate 
beverages, in the table below is an exhausted list of the potential ingredients found within the 
beverages you will be required to consume. Please note that the ingredients listed may not be in 
the all of the drinks. Please carefully read the list and declare if you wish to participate in this 
Study. 
 
Acacia 
Ascorbic Acid 
Aspartame 
Biloba 
Benzoate 
Berry Juice 
Fruit Juice 
Caffeine 
Calcium 
Camitne 
Camitne Fumarate 
D-ribose 
Ginkgo Biloba leaf extract 
Ginseng 
Glucose 
Glucuronolactone 
Glycerol Ester of wood rosin 
Grape seed extract 
Guarana extract 
Guarana seed 
Inositol 
L-Arginine 
L-Carnitine 
Maltodextrin 
Milk Thistle extract 
Niacinamide 
Pannax ginseng extract 
Pantothenate 
Pantothenic Acid 
Phosphorus 
Potassium 
Pyridoxine 
Riboflavin 
Sodium 
Sodium Citrate 
Sucrose 
Taurine 
Vitamin A 
Vitamin B2 
Vitamin B3 
Vitamin B5 
Vitamin B6 
Vitamin B12 
Vitamin C 
Vitamin D 
Vitamin E 
Vitamin K 
Yerba mate leaf extract 
 
 
I ………………………………….. declare that I have no known allergies or sensitivities to any 
of the ingredients found in the above list and wish to participate in this study. Initial…………… 
Please declare if you have any other known food or beverage allergies in the space allocated 
below. 
……………………………………………………………………………………………….……...
………………………………………………………………………………………………………
………………………………………………………………………………………………………
………………………………………………………………………………………………………
……………………………………………………………………………………………………… 
Signed 
……………………………………………………………………………………………………
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HAL set up procedures for Gainesville scenario 
 
1. Turn on all the lights. 
2. Open both HAL doors. 
3. Between two people carefully carry the chair, located behind the HAL, to the 
simulator. 
4. Retrieve the Gist laptop from its location behind the simulator. 
5. Turn on the Gist Laptop. 
6. Turn on the circuit breaker on the side of the simulator, immediately after turning 
on the Gist. 
7. Wait for the communication channel to be reached, the screen will change colors 
until arriving at the default Runway 7L DAB. 
8. Follow 172 setup checklists to initiate glass cockpit, ensure cockpit controls are 
set up for flight and ready for the scenario to begin.  
Flaps – Up  Standby Battery – On  
Mixture – Rich  Ignition – Both  
Throttle – Full  Parking Brake – In 
Trim – Neutral  Standby Static Source – In  
Electrical Switches – Off  Fuel Shutoff – In  
Master Switch – On  Fuel Selector – Both  
Avionics Switch – On  FREEZE – Red Button ON 
 On MFD – Press ENTER 
Gist setup is complete. 
9. To setup scenario on Gist laptop, begin on ENVIRONMENT icon. Click on 
CONDITIONS tab – set altimeter to 30.00.  Click on CLOUDS tab – On the first 
layer, select overcast, set top to 10,000 ft, set bottom to 0 feet MSL, select red 
stop sign; it changes to green.  VERIFY on Gist and Mentor Visual Display.  
Click on WINDS tab – consult approach plate and set top level wind 90 degrees 
left of the localizer (196 Degrees for GNV), select wind = 10 kts of wind, select 
gusts = 10 kts, repeat for second level and ground level, click DONE to confirm. 
10. Select the GLOBE Icon, Position to Station – from list select appropriate VOR for 
scenario, (Ocala OCF for GNV). Set range from Station to 24.5, set the radial to 
017, set the heading to 017, this is the same as the radial, select OK to confirm 
options.  VERIFY on PFD. 
11. Select aircraft ATTITUDE icon, consult approach plate and set initial altitude to 
be 1000 ft above the approach fix, (2700 for GNV), set heading to the lead-in 
radial, ( 017 for GNV), set pitch and bank to 0 degrees, set airspeed to 110 knots, 
select OK to confirm options. 
12. On Gist APPROACH display, select the airplane symbol, search for the airport 
using the identifier, select the runway to be used, select OK and the airport will 
change on the Gist approach display. 
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13. The Experimenter must now select the RECORD icon, select the red button.  
Ensure that the simulator is recording (time advancing). 
14. Set up is complete; now move the subject to the simulator chair with the 
appropriate approach plate. 
15. The experimenter will now read the subject the ATC command – “On the Ocala 
017 radial, descend and maintain 1700 Intercept the localizer, cleared for the ILS 
RWY 29 approach, altimeter 30.00, and squawk ………” (Participant number). 
16. Tell the subject to press the red pause button and begin the approach. 
17. Upon completion, select the RECORD icon, stop the recording, select file in the 
popup record window, save the file as participant number and date; select OK to 
save on hard drive. 
18. In the popup record window, select FILE EXPORT, select the just-saved file 
name, Windows Explorer will open, find the external USB, select file copy, and it 
will save. When complete select OK, It will ask are you sure you want to quit, 
select OK. 
19. Now experimenter must reset the simulator controls to flight-ready conditions.  
Repeat Steps 8-18 for next subject. 
20. When the testing day is concluded, select FILE on the Gist toolbar, shut down 
trainer, YES, wait until the lap top is off, close the laptop and stow away behind 
the simulator. 
21. Now turn off the simulator circuit breaker. 
22. Carefully return the chair to the original position behind the HAL. 
23. Sweep through the HAL to ensure it is returned to its original condition. 
 
NOTE: If the simulator and the Gist fail to communicate select CTRL ALT DEL and 
select turn off the computer, if option is not present, a hard shut down will be ok, but not 
advisable. 
 
REPORT HAL Problems to Glenn Harmon, phone: 6-6843 
REPORT Gist/Mentor Problems to Tom Haritos, phone: 6-6447 
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HAL set up procedures for Jacksonville scenario  
 
1. Turn on all the lights. 
2. Open both HAL doors. 
3. Between two people carefully carry the chair, located behind the HAL, to the 
simulator. 
4. Retrieve the Gist laptop from its location behind the simulator. 
5. Turn on the Gist Laptop. 
6. Turn on the circuit breaker on the side of the simulator, immediately aeer turning 
on the Gist. 
7. Wait for the communication channel to be reached, the screen will change colors 
until arriving at the default Runway 7L DAB. 
8. Follow 172 setup checklists to initiate glass cockpit, ensure cockpit controls are 
set up for flight and ready for the scenario to begin.  
Flaps – Up  Standby Battery – On  
Mixture – Rich  Ignition – Both  
Throttle – Full  Parking Brake – In 
Trim – Neutral  Standby Static Source – In  
Electrical Switches – Off  Fuel Shutoff – In  
Master Switch – On  Fuel Selector – Both  
Avionics Switch – On  FREEZE – Red Button ON 
 On MFD – Press ENTER 
Gist setup is complete. 
9. To setup scenario on Gist laptop, begin on ENVIRONMENT icon. Click on 
CONDITIONS tab – set altimeter to 30.00.  Click on CLOUDS tab – On the first 
layer, select overcast, set top to 10,000 ft, set bottom to 0 ft, select red stop sign; it 
changes to green.  VERIFY on Gist and Mentor Visual Display.  Click on 
WINDS tab – consult approach plate and set top level wind 90 degrees left of the 
localizer (164 degrees for JAX), select wind = 10 kts of wind, select gusts = 10 
kts, repeat for second level and ground level, click DONE to confirm. 
10. Select the GLOBE Icon, Position to Station – from list select appropriate VOR for 
scenario, (Craig CRG for JAX). Set range from Station to 8, set the radial to 006, 
set the heading to 006, this is the same as the radial, select OK to confirm options.  
VERIFY on PFD. 
11. Select aircraft ATTITUDE icon, consult approach plate and set initial altitude to 
be 1000 feet MSL above the approach fix, (3000 for JAX), set heading to the 
lead-in radial, ( 006 for JAX), set pitch and bank to 0 degrees, set airspeed to 110 
knots, select OK to confirm options. 
12. On Gist APPROACH display, select the airplane symbol, search for the airport 
using the identifier, select the runway to be used, select OK and the airport will 
change on the Gist approach display. 
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13. The Experimenter must now select the RECORD icon, select the red button.  
Ensure that the simulator is recording (time advancing). 
14. Set up is complete; now move the subject to the simulator chair with the 
appropriate approach plate. 
15. The experimenter will now read the subject the ATC command – “On the CRAIG 
006  radial, descend and maintain 2000 Feet MSL  Intercept the localizer, cleared 
for the ILS RWY 25 approach, altimeter 30.00, and squawk ………” (Participant 
number). 
16. Tell the subject to press the red pause button and begin the approach. 
17. Upon completion, select the RECORD icon, stop the recording, select file in the 
popup record window, save the file as participant number and date; select OK to 
save on hard drive. 
18. In the popup record window, select FILE EXPORT, select the just-saved file 
name, Windows Explorer will open, find the external USB, select file copy, and it 
will save. When complete select OK, It will ask are you sure you want to quit, 
select OK. 
19. Now experimenter must reset the simulator controls to flight-ready conditions.  
Repeat Steps 8-18 for next subject. 
20. When the testing day is concluded, select FILE on the Gist toolbar, shut down 
trainer, YES, wait until the lap top is off, close the laptop and stow away behind 
the simulator. 
21. Now turn off the simulator circuit breaker. 
22. Carefully return the chair to the original position behind the HAL. 
23. Sweep through the HAL to ensure it is returned to its original condition. 
 
NOTE: If the simulator and the Gist fail to communicate select CTRL ALT DEL and 
select turn off the computer, if option is not present, a hard shut down will be ok, but not 
advisable. 
 
REPORT HAL Problems to Glenn Harmon, phone: 6-6843 
REPORT Gist/Mentor Problems to Tom Haritos, phone: 6-6447 
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HAL set up procedures for St Augustine scenario  
 
1. Turn on all the lights. 
2. Open both HAL doors. 
3. Between two people carefully carry the chair, located behind the HAL, to the 
simulator. 
4. Retrieve the Gist laptop from its location behind the simulator. 
5. Turn on the Gist Laptop. 
6. Turn on the circuit breaker on the side of the simulator, immediately after turning 
on the Gist. 
7. Wait for the communication channel to be reached, the screen will change colors 
until arriving at the default Runway 7L DAB. 
8. Follow 172 setup checklists to initiate glass cockpit, ensure cockpit controls are 
set up for flight and ready for the scenario to begin.  
Flaps – Up  Standby Battery – On  
Mixture – Rich  Ignition – Both  
Throttle – Full  Parking Brake – In 
Trim – Neutral  Standby Static Source – In  
Electrical Switches – Off  Fuel Shutoff – In  
Master Switch – On  Fuel Selector – Both  
Avionics Switch – On  FREEZE – Red Button ON 
 On MFD – Press ENTER 
Gist setup is complete. 
9. To setup scenario on Gist laptop, begin on ENVIRONMENT icon. Click on 
CONDITIONS tab – set altimeter to 30.00.  Click on CLOUDS tab – On the first 
layer, select overcast, set top to 10,000 feet MSL, set bottom to 0 feet MSL, select 
red stop sign; it changes to green.  VERIFY on Gist and Mentor Visual Display.  
Click on WINDS tab – consult approach plate and set top level wind 90 degrees 
left of the localizer (222 degrees for SGJ), select wind = 10 kts of wind, select 
gusts = 10 kts, repeat for second level and ground level, click DONE to confirm. 
10. Select the GLOBE Icon, Position to Station – from list select appropriate VOR for 
scenario, (Ormond OMN for SGJ). Set range from Station to 29, set the radial to 
354, set the heading to 354; this is the same as the radial, select OK to confirm 
options.  VERIFY on PFD. 
11. Select aircraft ATTITUDE icon, consult approach plate and set initial altitude to 
be 1000 feet MSL above the approach fix, (4000 for SGJ), set heading to the lead-
in radial, ( 354 for SGJ), set pitch and bank to 0 degrees, set airspeed to 110 
knots, select OK to confirm options. 
12. On Gist APPROACH display, select the airplane symbol, search for the airport 
using the identifier, select the runway to be used, select OK and the airport will 
change on the Gist approach display. 
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13. The Experimenter must now select the RECORD icon, select the red button.  
Ensure that the simulator is recording (time advancing). 
14. Set up is complete; now move the subject to the simulator chair with the 
appropriate approach plate. 
15. The experimenter will now read the subject the ATC command – “On the 
Ormond 354 radial, descend and maintain 3000 Ft   Intercept the localizer, cleared 
for the ILS RWY 31 approach, altimeter 30.00, and squawk ………” (Participant 
number). 
16. Tell the subject to press the red pause button and begin the approach. 
17. Upon completion, select the RECORD icon, stop the recording, select file in the 
popup record window, save the file as participant number and date; select OK to 
save on hard drive. 
18. In the popup record window, select FILE EXPORT, select the just-saved file 
name, Windows Explorer will open, find the external USB, select file copy, and it 
will save. When complete select OK, It will ask are you sure you want to quit, 
select OK. 
19. Now experimenter must reset the simulator controls to flight-ready conditions.  
Repeat Steps 8-18 for next subject. 
20. When the testing day is concluded, select FILE on the Gist toolbar, shut down 
trainer, YES, wait until the lap top is off, close the laptop and stow away behind 
the simulator. 
21. Now turn off the simulator circuit breaker. 
22. Carefully return the chair to the original position behind the HAL. 
23. Sweep through the HAL to ensure it is returned to its original condition. 
 
NOTE: If the simulator and the Gist fail to communicate select CTRL ALT DEL and 
select turn off the computer, if option is not present, a hard shut down will be ok, but not 
advisable. 
 
REPORT HAL Problems to Glenn Harmon, phone: 6-6843 
REPORT Gist/Mentor Problems to Tom Haritos, phone: 6-6447 
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Appendix E 
Tables 
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Table 15 
AATD Output Means for Gainesville 
 
Gainsville 
Subject 
Localizer 
Deviations 
Glide-Slope 
Deviations 
Airspeed 
Deviations 
1 0.425 34.442 2.143 
2 0.812 19.917 4.644 
3 0.368 11.593 1.319 
4 1.671 13.705 1.759 
5 0.608 20.417 2.652 
6 0.334 34.376 2.190 
7 0.278 14.866 1.489 
8 0.201 11.877 1.528 
9 1.285 71.871 4.161 
10 0.480 14.204 2.764 
11 1.044 52.115 2.410 
 
Table 16 
AATD Output Means for Jacksonville 
 
Jacksonville 
Subject 
Localizer 
Deviations 
Glide-Slope 
Deviations 
Airspeed 
Deviations 
1 0.384 11.632 1.760 
2 0.707 39.259 4.444 
3 0.378 27.587 2.014 
4 0.368 8.250 2.444 
5 0.608 11.001 1.550 
6 0.574 43.600 1.880 
7 0.185 14.394 0.860 
8 0.175 18.826 3.210 
9 1.172 37.843 5.472 
10 0.266 8.061 0.737 
11 0.706 366.443 15.336 
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Table 17 
 
AATD Output Means for St Augustine 
 
St Augustine 
Subject 
Localizer 
Deviations 
Glide-Slope 
Deviations 
Airspeed 
Deviations 
1 0.185 14.394 0.860 
2 0.981 39.259 2.066 
3 0.214 13.865 1.189 
4 0.400 8.986 1.016 
5 0.706 48.176 2.361 
6 0.631 34.376 2.407 
7 0.184 14.866 1.964 
8 0.287 21.318 3.513 
9 0.890 72.337 3.143 
10 0.326 17.896 0.998 
11 1.018 22.860 4.237 
 
 
 
Table 18 
 
AATD Output Means for Red Bull
®
 
 
Red Bull
®
 
Subject 
Localizer 
Deviations 
Glide-
Slope 
Deviations 
Airspeed 
Deviations 
1 0.425 34.442 2.143 
2 0.981 39.259 2.066 
3 0.378 27.587 2.014 
4 1.671 13.705 1.759 
5 0.706 48.176 2.361 
6 0.574 43.600 1.880 
7 0.278 14.866 1.489 
8 0.287 21.318 3.513 
9 1.285 71.871 4.161 
10 0.326 17.896 0.998 
11 0.706 366.443 15.336 
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Table 19 
 
AATD Output Means for Monster
®
 
 
Monster
®
 
Subject 
Localizer 
Deviations 
Glide-Slope 
Deviations 
Airspeed 
Deviations 
1 0.384 11.632 1.760 
2 0.707 39.259 4.444 
3 0.368 11.593 1.319 
4 0.400 8.986 1.016 
5 0.608 20.417 2.652 
6 0.334 34.376 2.190 
7 0.184 14.866 1.964 
8 0.175 18.826 3.210 
9 0.890 72.337 3.143 
10 0.480 14.204 2.764 
11 1.018 22.860 4.237 
 
 
 
Table 20 
 
AATD Output Means for Placebo 
 
Placebo 
Subject 
Localizer 
Deviations 
Glide-Slope 
Deviations 
Airspeed 
Deviations 
1 0.185 14.394 0.860 
2 0.812 19.917 4.644 
3 0.214 13.865 1.189 
4 0.368 8.250 2.444 
5 0.608 11.001 1.550 
6 0.631 34.376 2.407 
7 0.185 14.394 0.860 
8 0.201 11.877 1.528 
9 1.172 37.843 5.472 
10 0.266 8.061 0.737 
11 1.044 52.115 2.410 
 
